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Abstract 
 
The effect of the interaction between gender and posterior cruciate ligament (PCL) 
prosthesis design on patient-reported outcomes is an understudied area of research. We 
evaluated 1613 patients, from the Ontario Joint Replacement Registry (2001-2006), who 
underwent primary total knee replacement. This study investigated the impact of the 
gender-PCL design interaction on Western Ontario and McMaster Universities 
Osteoarthritis Index (WOMAC) change scores and patient satisfaction, by performing 
linear regression analysis, using full-adjusted models that also included the gender-PCL 
prosthesis design interaction variable. PCL prosthesis design did not affect WOMAC 
change scores or satisfaction (p>0.05). Moreover, gender did not influence either of the 
patient-reported outcomes (p>0.05) in the adjusted model. In addition, the interaction 
between gender and PCL design did not impact patient-reported outcomes (p>0.05).  In 
conclusion, the surgical preference to retain or sacrifice the PCL should not be influenced 
by the gender of the patient.  
 
 
Keywords: Total knee replacement, PCL sacrificing, PCL retaining, Gender interactions, 
WOMAC, Patient satisfaction. 
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Introduction 
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A good understanding of the underlying anatomy and physiology of the knee is 
important to fully realizing the implications of the research conclusions.   
1.1. - Bone and joint anatomy  
One of the most important components of the human musculoskeletal system is 
the joint. The main functions of joints are effective load distribution, 
movement/locomotion and provision of stability. A joint is a point of articulation between 
two or more bones. This allows for mechanical support and/or movement. 
The biggest joint in the human body is the knee joint and it consists of two 
articulations. The first articulation is between the femur and tibia and the second is 
between the femur and patella. As a pivotal hinge joint, the knee permits extension and 
flexion, but very little medial and lateral rotation. Due to its function in supporting the 
majority of body weight, the knee joint is susceptible to injuries and degenerative 
osteoarthritis.  
As seen in Figure 1.1, the main components of the joint are cartilage, bone, 
synovial capsule (fluid and synovial lining) and meniscus 38. Moveable joints, such as the 
knee joint, are lubricated by synovial fluid, which is kept in the joint by the synovial 
capsule 38. The surfaces of the bones that contact each other are perfectly smooth because 
they are lined by articular cartilage composed of hyaline cartilage 38. In addition, 
ligaments limit medial, lateral, posterior and anterior movements of the bones involved in 
the joint. The ligaments of the knee joint limit unwanted movements and thereby provide 
stability. In addition to the menisci (cushioning cartilage disk in between the tibia and 
femur) and bursae, the ligaments of the knee also protect the knee capsule 38. These 
ligaments can be subdivided into the intracapsular and extracapsular ligaments 38.  
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Figure 1.1 - Schematic diagram of a typical synovial joint. A knee joint is an example 
of a synovial joint. It consists of two opposing bones. The geometry of bones is 
congruent. The tibial component is convex whereas the femur end is concave. This 
structure allows for movement and stability. The surface of the bones is covered by 
articular cartilage. The elasticity of the articular cartilage allows for load distribution. The 
knee joint is encapsulated by a synovial lining (synovium), which is one or two cell layers 
thick and is responsible for the production of the joint fluid. This diagram was adapted 
from madhero88 at Wikimedia commons (http://en.wikipedia.org/wiki/File:Joint.png) 
with permission. To see permission please refer to appendix F page 156 (F-156). 
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The intracapsular ligaments are ligaments that are within the articular capsule of 
the synovial joint. The first two ligaments are the anterior cruciate ligaments (ACL) and 
the posterior cruciate ligaments (PCL). The ACL connects the lateral condyle of the 
femur to the anterior part of the intercondyloid fossa as seen in figure 1.3. The ACL and 
the PCL wrap around each other during flexion and unwind in extension. The ACL has 
two bundles: the anteromedial and the posterolateral. These bundles are named according 
to where they insert into the tibial plateau. The ACL attaches in front of the 
intercondyloid eminence of the tibia. The ACL prevents the anterior movement and 
medial rotation of the tibia, in relation to the femur. 
The PCL connects the medial condyle of the femur to the posterior intercondylar 
area 38. In the average human adult, the PCL is 3.8 cm in length and 1.3 cm in width. This 
ligament prevents the posterior movements of the tibia in relation to the femur and also 
the anterior movement of the femur on the tibia 38. It provides 90-95% of the total 
restraint required for preventing the posterior displacement of the tibia 38. 
The architecture of the knee joint is very important in effective load distribution. 
As seen in Figure 1.2, the structure and flexibility of the articular cartilage and meniscus 
of the knee joint, allows for symmetric load distribution. The heavy load demonstration 
shows the focus of the weight in the middle of the knee joint. With increased weight 
bearing the articular cartilage of the femur and tibia are subject to more pressure and it is 
more likely for the patient to experience pain and trauma in their knee.   Furthermore, 
with increasing load, the articular cartilage of the femur and the tibia make more contact, 
but the load is still distributed symmetrically. Some studies suggest that degenerative 
osteoarthritis can result in asymmetric load distribution 40. 
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Figure 1.2 Comparison of light and heavy load distribution at the knee joint. This 
figure shows the distribution of varying loads on the knee joint. The structure of the knee 
joint allows for effective load distribution thereby providing stability during gait. In 
figure A, only a light load is applied to the knee. In figure B, a heavy load is applied to 
the knee. During the heavy loading, the articular cartilage of the femur and tibia make 
more contact to distribute the load in an even manner. This figure was adapted from 
iluvnutrifoods.com. 
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As Figure 1.3 shows, the location of the PCL is near the longitudinal axis of 
rotation and it is slightly medial to the center of the knee. Depending on the angle of the 
knee, the PCL is more vertical when the knee is extended and it is more horizontal when 
the knee is flexed. As the angle of knee flexion increases, there is more tension on the 
PCL. That is to say, maximal tension is achieved in full flexion of the knee. Although the 
ACL and PCL wrap around one another during flexion (X shape), the PCL takes a more 
direct course than the more spiral-shaped ACL fibers 41.  Furthermore, both the ACL and 
the PCL stabilize the medial and lateral side of the knee.  
Another intracapsular ligament is the transverse ligament, which connects the 
anterior portion of the lateral meniscus to the anterior portion of the medial meniscus. 
Lastly, the posterior and anterior meniscofemoral ligaments connect the posterior horn of 
the lateral meniscus and the lateral surface of the medial femoral condyle.  
The extracapsular ligaments are associated with the synovial joint, but are external 
to its capsule. The patellar ligament connects the tuberosity of the tibia to the patella. This 
ligament is very strong and functions as a cap for the condyles of the knee as well as 
supports the patella for mechanical leverage.  
The medial collateral ligament (MCL) connects the medial epicondyle of the 
femur to the medial tibial condyle 41. This ligament protects the medial side of the knee 
from being bent open when a stress is applied to the lateral side of the knee (valgus 
force). The lateral collateral ligament (LCL) connects the lateral epicondyle of the femur 
to the head of the fibula. It functions to protect the lateral side of the knee from a medial 
or varus force 41.  
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Figure 1.3 Schematic diagram of the anterior aspect of the knee joint. Three 
components of the knee joint are the femur, the patella and the tibia. The patella can be 
seen from the anterior aspect of the knee. When the knee is extended, the PCL becomes 
more vertical and when the knee is flexed the PCL becomes more horizontal. The ACL 
can also be seen from the posterior aspect, as it wraps around the PCL during flexion and 
unwinds during extension. The medial and lateral collateral ligaments prevent medial and 
lateral movements that would compromise the stability of the knee joint. This image was 
adapted by permission from Wikimedia.com (http://en.wikipedia.org/wiki/ 
File:Knee_diagram.svg), by Mysid  F-157.  
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The last two extracapsular ligaments are on the dorsal side of the knee. The 
oblique popliteal ligament connects the upper margin of the intercondyloid fossa and the 
posterior surface of the femur to the posterior margin of the head of the tibia. The arcuate 
popliteal ligament is “Y” shaped and is attached to the fibular head 41. It has two 
insertions on the intercondylar area of the tibia and the lateral epicondyle of the femur.   
 
1.1.1 Flexion and extension of the knee 
The knee allows not only for flexion and extension of the leg, but also for slight 
rotation medially and laterally in the flexed position. In a healthy subject, when the knee 
is fully straight we have zero degrees of flexion. As the knee is bent and the heel of the 
foot touches the buttocks we have 180 degrees of flexion and zero degrees of extension. It 
is important to discuss which ligaments are involved in this range of motion.  
In the fully extended position, the medial and lateral collateral ligaments are tense 
and stretched (taut). The medial collateral ligament is completely unfolded in the 
extended position.  Before the knee is fully extended, the knee rotates medially by five 
degrees, which is caused by the lateral rotation of the tibia. This is called the obligatory 
terminal rotation41. Stretching of the anterior cruciate ligament causes this rotation. The 
anterior and posterior cruciate ligaments are slightly unwound in the extended position, 
but the lateral ligaments become tense.  
 
1.2  – Histology of joint tissues 
The knee joint is made up of a number of connective tissues. On a macroscopic 
level, the function of connective tissue is to join, support and provide structure for tissues 
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and organs. There are two main types of soft connective tissues: loose connective tissues 
and dense connective tissues 39. Loose connective tissues include adipose and material 
located between cells throughout much of the body also known as the extracellular matrix 
(ECM). The main components of the ECM are proteoglycans, which are large 
macropolymers consisting of a protein core that is attached to many carbohydrate chains 
called glycosaminoglycans (GAGs). These chains are highly hydrophilic and are 
surrounded by water 39. This gives the tissue its thickness and firmness. Dense connective 
tissue or dense fibrous tissue has fibers as its main matrix element. It is mainly composed 
of type I collagen. Dense connective tissue makes up the structure of tendons and 
ligaments. Tendons attach skeletal muscles to bone, whereas ligaments attach bones to 
bones. Consequently, ligaments have more elastic fibers than tendons.  
The connective tissue components of the musculoskeletal system come from 
mesenchymal cells developmentally. The bone matrix is synthesized by osteoblasts; 
cartilage by chondrocytes; and ligaments and tendons by fibroblasts 39. The fibroblast has 
the ability to secrete fibrous material such as collagen and elastin 39. Collagen is a strong 
fibrous material that is found in connective tissues, including tendons, ligaments, 
cartilage, bone, intervertebral disks, blood vessels, skin and the cornea. Elastin is a 
protein in some connective tissues, and it functions to allow the connective tissue to 
stretch and regain its shape (elasticity). Adipocytes are fat cells, which store fat (energy). 
Chondrocytes produce and maintain the cartilaginous matrix. Depending on location in 
the tissue and the type of cartilage, the organization of chondrocytes can differ. Cartilage 
is a strong, but very flexible extracellular tissue. The three main types of cartilage are 
hyaline cartilage, elastic cartilage and fibrous cartilage 39. In general, unique features of 
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cartilage are that it is avascular, contains no nerves, has few cell-cell contacts, and the 
volume of extracellular matrix is much greater than the volume of cells.  
 
[i] Hyaline cartilage 
Hyaline cartilage is strong, slightly flexible and is the most abundant type of 
cartilage in the human body 39. For example, the larynx and the trachea are reinforced by 
hyaline cartilage. In the embryo, the hyaline cartilage develops from loose connective 
tissue when the oxygen supply is low; whereas, bone develops from the same tissue when 
oxygen is abundant. In the fetus, the hyaline cartilage forms much of the skeleton and is 
replaced by bone during endochondral bone formation. After birth and up to the end of 
adolescence, hyaline cartilage makes up the epiphyseal growth plates, which control the 
growth and shape of long bones. Hyaline cartilage also lines the articular surfaces of 
synovial joints, where it acts as a self-lubricating shock absorber and provides a low 
friction surface for movement. Articular cartilage lacks blood vessels and, therefore, can 
be irreversibly damaged by overuse or infection. Inflammation of the joint leads to 
destruction of the articular cartilage, which causes pain and stiffness. Damaged hyaline 
cartilage can only be repaired to a limited extent 39.  
Except where hyaline cartilage serves as articular cartilage and is exposed to 
synovial fluid, it is enclosed by the perichondrium, which is essential for the growth of 
cartilage. The perichondrium is a layer of dense irregular connective tissue, which 
surrounds the cartilage of developing bone. It consists of two separate layers: an outer 
fibrous layer and inner chondrogenic layer. The fibrous layer contains fibroblasts, which 
produce collagenous fibers. The chondrogenic layer remains undifferentiated and can 
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form chondroblasts or chondrocytes. Perichondrium can be found around elastic cartilage 
and hyaline cartilage. Thus, the perichondrium is thought to have a significant role in the 
growth and repair of cartilage. Once vascularized, the perichondrium becomes the 
periosteum 39.  
Chondrocytes in hyaline cartilage are grouped in pairs of four to six cells known 
as an isogenous nest, because they are the progeny of a single chondrocyte during 
development. The matrix is composed of type II collagen fibers, water and proteoglycans 
(PGs).  Chondrocytes of hyaline cartilage synthesize and maintain all components of the 
extracellular matrix.  The majority of the matrix is water and it is the water and inorganic 
salts that give cartilage its resilience and lubricating capabilities.  PGs in the matrix are 
negatively charged and thus attract large amounts of positively charged ions and water. 
The remaining constituents are structural macromolecules: collagens, PGs and non-
collagenous proteins.  
Roughly 90-95% of the collagen in hyaline cartilage is type II collagen which 
provides a fibrillar meshwork that gives hyaline cartilage its tensile strength. PGs in the 
matrix are negatively charged and hold large amounts of positively charged water ions. 
Figure 1.4 shows that PGs are composed of core protein with complex carbohydrates 
called glycosaminoglycans (GAGs) that radiate from the core. These GAGs consist of 
repeating negatively charged disaccharide units of various lengths, which may or may not 
be sulphated. The sulphated PGs such as chondroitin sulphate, dermatan sulphate and 
keratin sulphate, attach noncovalently to hyaluronic acid in order to form large PG 
aggregates known as aggrecans. The interaction among water, the collagen fibril network 
and aggrecans give cartilage its resilience and its ability to resist/balance compression 37. 
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Figure 1.4 - Schematic diagram of a proteoglycan complex. The proteoglycans are 
responsible for the integrity of the cartilaginous material in articular joints. The main 
components of the extracellular matrix (ECM) are proteoglycans, which are large 
polymers consisting of a protein core with many attached carbohydrate chains. The 
carbohydrate chains are called glycosaminoglycans (GAGs). There are multiple types of 
GAGs, which include keratin sulphate and chondroitin sulphate, and are extremely 
important for the integrity of the ECM. Like all carbohydrates, they are very hydrophilic. 
Hence, in the body, they are always surrounded by a large amount of water (water of 
solvation). This gives tissues their characteristics thickness and firmness. Dehydration 
results in decreased hydration of the ECM and thus jeopardizes its integrity.  This 
diagram was adapted with permission from “Histology and cell biology” by Abraham L. 
Kierszenbaum, Mosby, 2002 F-158. 
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[ii] – Elastic cartilage 
Elastic cartilage possesses a matrix dominated by elastic fibers 39. The matrix 
contains a small number of type II collagen fibers that are covered by proteoglycans, 
combined with more abundant elastic fibers. Elastic cartilage is also enclosed by a 
perichondrium. Physiologically, elastic cartilage does not calcify with age 39. Elastic 
cartilage and hyaline cartilage are found in structures such as the epiglottis and the outer 
ear, where more flexibility is required than hyaline cartilage can provide. In particular, 
elastic cartilage contains elastin.  
 
[iii] – Fibrous cartilage 
Fibrous cartilage is very rigid and is found in places where structural strength is 
important such as the pubic symphysis and the intervertebral disks of the spinal column 39. 
It is a mixture of dense regular connective tissue and hyaline cartilage. It combines the 
tensile strength, firmness and durability of tendon with the resistance to compression of 
cartilage. In contrast to other types of cartilage, fibrocartilage lacks perichondrium. 
Fibrocartilage initially forms from dense connective tissue that is rich in fibroblasts, some 
of which differentiate into chondrocytes. Therefore, a mixture of chondrocytes and 
fibroblasts is characteristic of this tissue 39. 
 
1.3.  - The structure and development of bone 
The osteocyte or bone cell has many functions, which include signal transmission 
39. In particular, osteocytes are thought to be mechanosensory cells that regulate the 
activity of osteoblasts and osteoclasts. Osteoblasts deposit bone matrix known as osteoid, 
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which includes type I collagen and proteoglycans. Osteoblasts also express alkaline 
phosphatase, which helps to mineralize the osteoid via production of inorganic phosphate 
leading to formation of calcium phosphate crystal in the form of hydroxyapatite. Hence 
osteoblasts are the bone making cells. Osteoclasts on the other hand, resorb bone and 
mineralized cartilage matrix 39. 
Bone is collectively made of spongy/cancellous bone as well as compact/cortical 
bone. The human musculoskeletal system is made of long bones (e.g., the femur in the 
thigh), short bones (e.g., carpal bones in the wrist), flat bones (e.g., calvaria of the skull) 
and irregular bones (e.g., spinal vertebra). The bones of the limbs are long bones and they 
are important for support and movement. The main shaft of the long bone is called the 
diaphysis. This part is a tube composed of only compact bone. The bone marrow is a non-
bony material found in the shafts of long bones and in the pores of spongy bones. The 
flared ends of a long bone are called the epiphyses. Long bones are the main bony 
component involved in the knee joint. 
 
1.3.1  - Overview of bone formation 
Bone formation is comprised of a series of complex and simultaneous processes, 
which include: cell migration, mitosis, differentiation, synthesis and secretion of ECM, 
mineralization, and resorption. Bones are formed by either intramembranous or 
endochondral ossification. Bone formation can be categorized either by bone forming on 
a cartilage (endochondral model) or not (intramembranous model) 39.  
Intramembranous ossification occurs in areas of ordinary mesenchyme where 
osteoblasts differentiate directly within richly vascularized connective tissue 39. Flat bones 
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of the cranium, part of the mandible and the clavicles develop in this way. Endochondral 
ossification is the method by which long bones and bones in the vertebral column, ribs 
and pelvis develop 39. Here, mesenchymal cells differentiate into chondrocytes. A 
cartilage template is first formed and then modified to facilitate osteogenesis. After bone 
forms, it remains dynamic throughout life to allow for remodelling in response to changes 
in functional demands and to serve as a source of mineral ions for homeostasis. Although 
this study focused on long bones, it is important to differentiate the two types of bone 
formation. Table 1.1 summarizes the two processes side by side. It is primarily 
endochondral bone formation that leads to formation of the long bones of the knee joint.  
 
[i] Intramembranous bone formation 
Intramembranous bone formation begins during gestation when mesenchymal 
cells move to sites of richly perfused/vascularized connective tissue and differentiate into 
osteoblasts39. The osteoblasts secrete osteoid, which consists of Type I collagen fibers, 
osteopontin, osteonectin, osteocalcin, fibronectin and a matrix of proteoglycans. 
Osteoblasts also secrete alkaline phosphatase, which is an enzyme that facilitates the 
mineralization of the osteoid by precipitation of inorganic calcium phosphate salts. That 
is to say, hydroxyapatite is the dominant mineral of the bony matrix. During the 
ossification process, osteoblasts become trapped and they eventually become osteocytes 
in small lacunae. The osteocytes are connected to one another via processes that lie in 
small channels called canaliculi. Small islands or trabeculae of newly formed bone are 
initially laid down. The osteoblasts arrange themselves on trabeculae surfaces and 
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continue to produce bony matrix. Trabeculae thicken and later merge to produce a three-
dimensional lattice structure of spongy bone39.  
Then the osteoclasts eventually kick in to continue the remodeling process. 
Eventually, the deposition of concentric layer or lamellae of matrix around the trapped 
blood vessels forms the functional units known as osteons. Lastly, the layer of specialized 
connective tissue around the developing bone becomes the periosteum39.  
 
[ii] Endochondral bone formation  
Endochondral bone formation begins with hyaline cartilage replicas of future adult 
bone39. Once developed from mesenchyme, the cartilage templates take the shape of the 
future bone. The first of the two ossification centers (POC) appears in the diaphysis/shaft 
of the cartilage template. Bone is laid down directly by connective tissue perichondrium 
of the cartilage. Eventually the perichondrium becomes the periosteum. Once deep into 
the new bone, the chondrocytes hypertrophy and die.  
From the periosteum blood vessels (periosteal bud) span the diaphysis interior and 
bring in mesenchymal and osteoprogenitor cells. At this point, the cartilage in the center 
starts to erode and the primitive marrow cavity starts to form. Incoming blood vessels 
carry primitive bone marrow cells. The proliferation of remaining chondrocytes causes 
the two ends or epiphysis to grow longitudinally. That is to say, the interior diameter of 
the diaphysis remains constant. This way, the chondrocytes are arranged in columns and 
appear as two fronts on both sides of the central region39. 
Eventually the epiphyseal growth plates are formed at the junction between epiphysis 
and diaphysis. It is the growth plates of hyaline cartilage that determine the longitudinal 
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diaphysis growth. After birth and continuing into puberty, ossification centers appear in 
the two epiphyses of long bones, until adolescence is reached when the growth plates 
eventually close and growth ceases39. 
 
1.3.1.1 - Structure and function of the growth plate  
A cartilaginous growth plate in a typical long bone provides temporary 
scaffolding on which new bone is laid down, permitting longitudinal bone growth. The 
plate stimulates appositional growth of hyaline cartilage at the end facing the epiphysis. 
Cartilage destruction in lower regions and replacement with primary spongy bone in the 
deepest region follows. Figure 1.5 shows the five distinct transverse zones of the growth 
plate reflecting the sequence of events in endochondral ossification.  
 
1. The reserve zone (resting cartilage) consists of small clusters of flattened, rounded 
and randomly arranged quiescent chondrocytes 39.  
2. In the proliferation zone, chondrocytes undergo rapid mitosis as a result of stimulation 
by growth hormone. No lateral cellular displacement occurs, and the new cells are 
stacked into columns. These cells are parallel to the long axis of the growing bone 39. 
3. In the zone of maturation and hypertrophy, mitosis stops. The cells in this region 
produce matrix and then enlarge followed by buildup of lipids, glycogen and alkaline 
phosphatase 39.  
4. In the zone of provisional calcification, spicules of calcified cartilage matrix are left 
behind. Dead chondrocytes are resorbed and lacunae erode. Now, the highly 
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vascularized primary marrow extends into the newly opened spaces and osteoblasts 
differentiate from mesenchymal cells in the bone marrow 39.  
5. In the ossification zone, the osteoprogenitor cells differentiate into osteoblasts. 
Osteoblasts secrete osteoid, which becomes mineralized (calcified), on the surface of 
calcified cartilage. Eventually this is followed by the remodeling of the calcified 
cartilage/calcified bone complex 39. 
 The metaphysis, at the distal end of the growth plate between the epiphysis and 
diaphysis is formed by slender calcified cartilage spicules 38. These project from the 
epiphyseal growth plate into the marrow cavity of the diaphysis. The metaphysis is also 
filled by many capillary loops that transport cells that become osteoblasts, which deposit 
bony matrix on calcified cartilage remnants. The metaphysis is divided into two 
functional regions. The upper one or the primary spongiosa contains capillary sprouts 
between missed spicules, which consist of a core of calcified cartilage covered by a thin 
layer of newly formed bone 38. The lower end of the metaphysis is the secondary 
spongiosa in which the calcified cartilage in the mixed spicules is ultimately resorbed by 
osteoclasts followed by secondary remodeling of spongy bone 38. This results in the 
lengths of the spicules remaining almost constant as the marrow cavity volume gradually 
increases. Growth in length continues until adulthood under the influence of growth 
hormone, thyroid hormone, parathyroid hormone and androgens 38. At skeletal maturity, 
epiphyseal growth stops and the epiphysis and diaphysis join.  
 
Osteoblasts 
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Osteoblasts synthesize and secrete osteoid, which consists mainly of type I 
collagen and non-collagenous glycoproteins such as osteocalcin, osteopontin, osteonectin 
and fibronectin 39. These cells also synthesize alkaline phosphatase, a cell surface protein 
that promotes mineralization.  Long branched cytoplasmic processes extend from cell 
bodies at the side where bone matrix is formed and penetrate deeply into osteoid to 
communicate with osteocyte processes. It is reported that gap junctions between the cells 
probably play a role in signal transmission 39. Osteoblasts respond to parathyroid 
hormone, estrogen, progesterone, and a number of other hormones and paracrine factors.  
 
Osteocytes 
Osteocytes are essentially mature osteoblasts 39. They have a high nucleus to 
cytoplasm ratio and relatively few cytoplasmic organelles. They reside in lacunae within 
the bone matrix. They have many cytoplasmic processes that extend into thin channels or 
canaliculi in the mineralized matrix 39. The processes of one cell are linked to others via 
gap junctions. Extracellular fluid in canaliculi permits transfer of molecules, oxygen and 
nutrients by diffusion. Some authors have proposed that one of the main jobs of 
osteocytes is to actively maintain bone matrix by exchange of calcium ions and other 
minerals with extracellular fluid 39.   
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Figure 1.5 – Schematic diagram of the epiphyseal plate. The first zone is the resting 
zone (zone of reserve cartilage) in which the precursor cells are flattened, randomly 
arranged and inactive. In the proliferation zone, the chondrocytes become active and 
rapidly undergo mitosis when stimulated by growth hormone. The new daughter cells 
grow in columns parallel to the long axis (vertical axis) of the future bone. Once in the 
hypertrophic zone, mitosis stops and the cells enlarge and accumulate glycogen, lipids 
and alkaline phosphatase. This will lead to the mineralized zone where eventually 
osteoprogenitor cells develop into osteoblasts and secrete osteoid. This osteoid becomes 
mineralized into bone. This figure was adapted with permission, from the nature 
publishing group F-159.  
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 Osteoclasts 
Actively resorbing osteoclasts reside in or near surface cavities known as 
Howship’s lacunae 39. A characteristic of osteoclasts is their ruffled borders (extensively 
folded membrane), which facilitates bone resorption by increasing surface area. The 
border membrane contains proton pumps that keep pH low (acidic) in the resorption 
cavity. The inorganic minerals of the matrix are dissolved when H+ ions are transported 
into the extracellular space. In addition, lysosomes release hydrolytic enzymes (e.g. 
collagenase) into the resorption cavity to degrade the organic components of the matrix. 
Osteoclasts are capable of resorbing bone and calcified cartilage matrix.  
 
1.3.2 - Bone Healing 
 Healing of bones can occur by both intramembranous and endochondral 
ossification39. The repair process starts as an inflammatory phase, followed by a 
reparative phase. The repair process ends with the bone-remodeling phase 39. During the 
reactive or inflammatory phase, there is blood clot formation and vasoconstriction to stop 
the bleeding. This is followed by apoptosis of the surrounding cells, but the mesenchymal 
cells survive and replicate 42. A loose aggregate of new cells are formed, intertwined with 
small blood vessels (granulation tissue). During the reparative phase, the periosteal cells 
differentiate into chondroblasts to produce hyaline cartilage or osteoblasts to form woven 
bone. The hyaline cartilage and woven bone grow in size until the fracture gap is bridged. 
The woven bone and hyaline cartilage (collectively known as fracture callus) are 
eventually replaced by lamellar bone (higher strength) during the remodeling phase, via 
endochondral ossification. At the end of the reparative phase, all of the woven bone and 
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cartilage of the fracture callus are replaced by lamellar bone 42. This ensures that the new 
repaired bone is close to the bone’s original strength. In the last stage, the bone is 
remodeled 39. This is accomplished first via the resorption by osteoclasts and then the 
osteoblasts deposit bone within the resorption pits. Eventually the callus is fully 
remodeled to the bone’s original shape and strength 42.  
 
1.4 - Degenerative Osteoarthritis  
 Osteoarthritis (OA) is a degenerative disease of the joint that can be caused by 
both systemic and local factors20. Figure 1.6 shows the cartilage erosion as well as 
asymmetric joint space narrowing. Some of the risk factors for osteoarthritis include 
advanced age, female sex, genetics, obesity, and occupations involving overuse or trauma 
9, 20. OA is characterized by pain that typically worsens with weight bearing and activity, 
and improves with rest 32. There is tenderness on palpation as well as bony enlargement of 
the involved joint, crepitus on motion, and limitation of joint movement 20.  
 OA has a large impact on the Canadian population.  It affects three million (or one 
in ten) Canadians 4, 7. It is also associated with significant costs to the Canadian economy, 
directly through drugs and use of healthcare resources and indirectly through lost 
employment time and costs of informal caregiving 8. On average, OA has an insidious 
onset 20. At a younger age, males are more affected than females; whereas, at an older 
age, women are more affected than men 4. Without treatment, people with OA are left 
with significant pain and loss of health-related quality of life 9. This study focuses on the 
surgical treatment for OA of the knee joint.  
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Figure 1.6 – The anterior view of the knee with severe degenerative osteoarthritis. 
This is a schematic diagram (A) as well as an X-ray (B) of a left knee with OA. On the 
left, there is erosion of the cartilage and patches of bone exposed. There is also formation 
of bone spurs (osteophytes). In panel B, there is asymmetric joint space narrowing 
(presented by the black arrow) as well as sclerosis of the subchondral bone (presented by 
the black arrow), which can be seen as parts of the bone that appear more white compared 
to the surrounding bone. Subchondral sclerosis associated with OA is localized and can 
be caused by injuries that compress the bone.  Figure A was adapted with permission 
from Nucleus Medical Media F-160 and Figure B was adapted with permission from 
Wikimedia (http://en.wikipedia.org/wiki/File:Osteoarthritis_ 
left_knee.jpg) originally made by Dr. James Heilman F-166.  
 
 
 
 
BA
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It is important to note the differences of OA as compared to osteoporosis 30. 
Osteoporosis is a systemic skeletal disease characterized by low bone density and 
microarchitectural deterioration of bone tissue with a gradual increase in bone fragility 30. 
OA involves deformation and degradation of joints, including articular cartilage and 
subchondral bone. Essentially with OA, there is a degradation of this macromolecular 
framework. There is a disruption of collagen through an increase in levels of proteinases 
and trauma37.   
In OA, the ECM is initially disrupted through an increase in metalloproteinase 
(MMPs), which attracts more water, and it is this abnormality that disorganizes the 
meshwork 37. The increase in edema decreases the elasticity of the cartilage and joint and 
causes a loss in lubrication, making simple movements extremely difficult.  
The clinical symptoms of degenerative osteoarthritis are joint pain, some swelling, 
painful movements, affected small and large joints, both unilateral and bilateral, and 
deformity in some joints. This deformity causes a loss of function. These symptoms have 
a gradual onset. The main clinical diagnosis of OA is through clinical presentation and 
physical examination. Medical imaging may show asymmetric joint space narrowing, 
subchondral cysts, sclerosis and osteophyte formation 37.  
Figure 1.7 shows that OA can be subdivided into three stages. In the first stage, 
there will be micro cracks in the articular cartilage and there will be areas of chondrocyte 
loss, alternating with chondrocyte proliferation. In the second stage, there may be 
vascularization of the knee joint, which is not normally evident. There will also be 
chondrocyte death and matrix degradation. In the third stage, there will also be synovial 
inflammation, but not as much as in rheumatoid arthritis.   
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Figure 1.7 – Progression of degenerative osteoarthritis. This is a schematic of the three 
stages of OA. Figure A shows a normal healthy synovial joint. In the first stage (B), there 
is ECM edema. The cartilage layer is affected and there is a loss of cartilage smoothness. 
In the second stage (C), the micro cracks from the first stage deepen with fissure 
formation. There are chondrocyte clusters around the fissures. In the third stage (D), the 
fissures from the second stage may eventually lead to breaking off of cartilage pieces, 
known as loose bodies. More importantly, the subchondral bone is exposed. Eventually 
osteophytes surround the area leading to sclerosis. Subchondral ‘cysts’ may form in the 
bone.  This image was adapted with permission F-161 from thelukinskispineclinic.com 
information website.  
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It is important to clarify what is expected with normal aging versus osteoarthritis. 
In normal aging, the water content of the cartilage decreases, which decreases the 
firmness 43. There is also a decrease in synthetic activity, which leads to less proteoglycan 
content, length and synthesis. Although this is normal, this will lead to decreased strength 
and firmness of the cartilage 43.  One important factor is that, with normal aging, the 
amount of collagen in the cartilage does not change 43. On the other hand with OA there is 
a substantial reduction in collagen in the cartilage. As well, there is a reduction in 
proteoglycan amount. In OA, there is a substantial increase in matrix metalloproteinases 
(MMPs), which is not evident in normal aging. Although MMPs have natural roles in the 
body, their overproduction leads to destruction of collagen. Eventually deformation of the 
joint may result 43. 
 
1.4.1 – Treatments for osteoarthritis 
 The main goals for treatment of OA are pain reduction, improved function, 
changes in the disease outcome, low cost, and minimal side effects. There are three broad 
categories of treatment for OA: non-pharmacological, pharmacological and surgical. The 
three treatment categories are described based on the clinical practice guidelines provided 
by Osteoarthritis Research Society International (OARSI) recommendations, the 
American Academy of Orthopaedic Surgeons (AAOS) guidelines and the National 
Institute of Health and Clinical Excellence (NICE) 75-78.  
 
1.4.1.1 - Non-pharmacological treatments for OA 
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All three guidelines recommend that a patient diagnosed with osteoarthritis, 
should receive education and be taught self-management techniques for treatment75-78. The 
non-pharmacological approaches recommended by the three guidelines are mainly 
physical and occupational therapy. Patients are educated on the options available and are 
advised to wear proper footwear and use assistive devices when needed. The three 
guidelines also recommend strength training as well as weight loss exercises75-78. In 
physiotherapy, patients are given muscle strengthening, aerobic, aquatic and range of 
motion exercises. In particular manual therapy includes passive or active movement 
techniques that use applied force to improve the mobility of the affected joints. Some of 
the techniques that the physiotherapist might use are soft tissue massage, stretching and 
passive movements, mobilization and manipulation of the soft tissue and joints75-78. As 
recommended by the OARSI guidelines76, in occupational therapy, patients are given 
orthotics, splints and braces or, more commonly, canes and walkers. The NICE guidelines 
also show evidence that walking aids can help can improve stride length and cadence and 
thus alleviate walking for knee OA patients78. For heavier patients (i.e. BMI>25) all three 
guidelines75-78 strongly recommend some kind of weight loss program to help with the 
functional disability associated with knee OA.   
 
1.4.1.2 - Pharmacological treatments for OA 
The pharmacological approach includes oral and topical medications that reduce 
pain and inflammation34. For example, all three guidelines recommend acetaminophen as 
an effective oral analgesic for pain relief 75-78. Intra-articular medications such as 
hyaluronic acid are also used, albeit with inconsistent clinical results. There are no 
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pharmacological treatments that change the course of the disease (i.e. disease modifying 
drugs) 28. The available medications serve mainly to reduce pain and swelling 28. The most 
common pharmacological treatments mentioned by the three guidelines are analgesics 
(Tylenol and opioids), Non-Steroidal Anti-Inflammatory Drugs  (topical NSAIDs and 
oral NSAIDs), glucosamine/chondroitin, intra-articular hyaluronic acid, and intra-
articular steroids to reduce inflammation.  
 
1.4.1.3 - Surgical treatments for OA 
Most patients with OA are referred for surgical treatment when other treatments 
are ineffective and function is severely impaired. Surgical treatment is usually the last 
resort. The most common surgical treatments are arthroscopy and debridement, 
osteotomy, ligament repair, joint reconstruction, grafting and total joint replacement. This 
study focuses on total joint replacement as a surgical treatment for OA of the knee joint. 
In particular, for a primary unilateral total joint replacement, the articular surfaces of a 
single knee joint are replaced for the first time 12. 
 
1.5 – Total Knee Joint Arthroplasty  
Total joint arthroplasty remains the top treatment for OA of the knee.5, 15 With 
high success rates, total knee arthroplasty (TKA) remains the last resort for patients 
suffering from OA. The components used in a total joint replacement are designed to 
enable the artificial joint to move like a normal joint. The prosthesis used in TKAs, is 
generally composed of two parts: a metal piece that fits closely into a matching sturdy 
plastic piece. Usually there are several metals used, including stainless steel, alloys of 
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cobalt and chrome, and titanium. These materials are strong, dense and appear as very 
opaque in X-rays, when compared to the surrounding bone. The plastic material (ultra-
high molecular weight polyethylene) is very durable and is resistant to wear, but is not 
easily detectable in X-rays.  
 For the component fixtures, the femur, tibia and patella can be cemented. 
Sometimes, the surgeon might choose to cement only the femur and tibia as seen in 
Figure 1.8. Depending on the preoperative stage of the patient, it may not be necessary to 
cement all three components for fixation of the prosthesis.  
 
1.5.1 - Posterior cruciate ligament (PCL) prosthesis design  
Prosthetic design for TKA has evolved into designs that either preserves the 
posterior cruciate ligament (PCL retaining) and those in which the ligament is sacrificed 
(PCL sacrificing). In patients with a functional PCL, the decision on which design is 
chosen depends largely on the preference of the surgeon, but there are many reasons why 
the PCL may be sacrificed or retained. Each option has its own advantages and 
disadvantages 1. In either case, the implants used have specific geometry to account for 
the presence or absence of the ligament. 
One of the most important reasons for retaining the PCL is to aid in 
proprioception 12, which is body’s sense of limb position based on stretch receptors or 
mechanoreceptors in ligaments and the amount of force employed in movement. This 
makes activities like climbing stairs, feel more stable/manageable.  
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Figure 1.8 – Schematic diagram of the left knee prosthesis from the anterior and 
medial point of view. On the left, the anterior view of the knee is shown. The femur and 
the tibial component have been cemented in this knee. On the right, the medial view of 
the left knee is shown. This image was adapted with permissionF-160 from the Nucleus 
Medical Media.  
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The other reason is that the ligament can promote more normal front to back knee 
motion. This is important for helping knee flexion. The implant used in these cases 
(cruciate retaining) is specifically designed to allow for the presence of the PCL. 
For the PCL to perform its function, it must be in a healthy condition. The PCL 
must be properly balanced/fitted after the knee prosthesis has been oriented and implanted 
by the surgeon. This can sometimes be difficult and, thus, the result is less predictable 
from patient to patient. One possible disadvantage of keeping the PCL is that the medial 
collateral ligament (MCL) and lateral collateral ligament (LCL) must be properly 
balanced as well. This is more difficult when the PCL is retained. Also, tension in the 
PCL created by surgery increases the tension on MCL and LCL and other structures 1, 12, 25.  
Figure 1.9 shows an X-ray of a PCL retaining prosthesis.  
On the other hand, when the PCL is sacrificed, special geometry in the implant 
components substitutes for the function of the ligament 25, 33. When the surgeon removes 
the PCL, the space between the prepared femur and tibia become larger, making access 
easier. In the meantime, the MCL and LCL tension created by PCL retention is reduced. 
Furthermore, since the ligament is now replaced by very consistent implant geometry, 
results tend to be similar among patients. Figure 1.10 is a sample of PCL sacrificing 
prosthesis.  
For PCL sacrificing prosthesis, the design must provide anteroposterior stability. 
This is accomplished by having congruent geometry in flexion in order to avoid sagittal 
instability. This geometry allows for uniaxial flexion with less flexion arc and produces 
quadriceps force, which is weaker.  
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Figure 1.9 – X ray of PCL retaining prosthesis. This is x ray image of the 
anteroposterior (A) and lateral (B) view of the knee of a 55-year-old woman who received 
a PCL retaining prosthesis. This picture was adapted from an article by Kolisek et al., 
2009 with permission F-162.    
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Figure 1.10 – X ray of PCL sacrificing prosthesis. This is an anteroposterior (A) and 
lateral (B) radiograph of a knee of a 52-year-old woman who received a PCL sacrificing 
prosthesis. This picture was adapted from an article by Kolisek et al., 2009 with 
permission F-162.  
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For PCL retaining prosthesis, by keeping the PCL, along with low constraint on 
the tibial component, allows for normal roll back of the femur on the tibia with knee 
flexion. This roll back allows for a better quadriceps lever arm than the PCL sacrificing 
prosthesis. It also allows for more efficient use of the extensor muscles, thereby allowing 
the patient to climb stairs easily 63. 
 
1.6 - Ontario Joint Replacement Registry (OJRR)  
 There have been numerous registries created that were designed to capture the 
preoperative and postoperative states of patients undergoing joint arthroplasty. A few 
examples include the American Joint Replacement Registry (AJRR) in the United States, 
National Joint Registry (NJR) in United Kingdom and the Swedish knee arthroplasty 
register in Sweden. In particular, the Ontario Joint Replacement Registry (OJRR) 
captured many variables, which are of prime importance for researchers and health care 
practitioners interested in knee arthroplasty outcomes. The OJRR collected data 
prospectively from participating orthopaedic surgeons in southwestern Ontario with about 
two million people and an ethnically diverse sample. This patient sample is representative 
of Canada’s ethnically diverse population. The surgical outcomes reported by the OJRR 
are similar to those found in the peer-reviewed literature9. Furthermore, key demographic 
variables in the OJRR database show similar distributions as those found in the Canadian 
joint replacement registry9. Thus the OJRR database has high external validity (whether 
our measurement corresponds to the real world). The internal validity of this database is 
less than that of a clinical trial; nonetheless, the data were collected prospectively for this 
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observational cohort study. Higher internal validity could have been achieved through a 
randomized cohort.  
 The OJRR data are part of the Canadian Joint Replacement Registry (CJRR). 
Data from the CJRR can be used for quality improvement, research and statistical 
analyses. Conclusions drawn from the analyses can be used as general information to 
inform policy and clinical treatment planning and decisions affecting specific patients. 
Like the CJRR, the OJRR provides information on distribution and frequency, and 
characteristics of total knee replacement surgeries, including the effectiveness of the 
surgical methods, long-term outcomes and how to minimize post-operative 
complications. The information gathered is intended to help determine which approaches 
are effective in specific circumstances and to determine which patients can most benefit 
from total knee replacement.  
 Since 2003, 67% of Ontario orthopaedic surgeons participated in the OJRR. OJRR 
is a robust dataset and it is generally applicable to the Canadian healthcare system. 
According to CIHI, orthopaedic surgeons in Ontario participated in the CJRR through the 
OJRR. Meanwhile, surgeons from other provinces submit data directly to CIHI. Surgical 
information in Ontario was collected via hand-held computers in the operating room. The 
data was sent electronically to CIHI by the OJRR.  
Given the nature of OJRR, the information from the CJRR will help evidence-
based practice and help inform guidelines for total knee replacements in Canada. There 
were 496 variables measured in the OJRR database. For the type of variables collected, 
please refer to appendix D. Following an extensive literature review (summarized below), 
we picked for our study a number of variables of interest, selected for their ability to 
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predict surgical outcomes. Two main components measured in the OJRR are patient-
reported outcomes: 1) the Western Ontario and McMaster Universities Osteoarthritis 
Index (WOMAC) questionnaire; and 2) the patient satisfaction questionnaire. The 
variables included in these questionnaires are extremely important, as they include 
measurement of health related quality of life (HRQoL) and functional outcome.  
 
 1.7 – Patient-Reported Outcomes 
Overall, there are multiple factors responsible for the success of TKA surgery (i.e. 
benefit to the patient) 7, 11. Although these surgeries have different success rates for men 
and women, these operations restore function and increase mobility in both men and 
women as measured by validated measurements of self-reported functional outcome 29.  
Many studies measure functional outcome/recovery to assess the results of TKA surgeries 
8, 11, 29. Clinically, one method of measuring functional outcome is through patient-reported 
outcomes such as the WOMAC. Functional recovery is multifactorial and it correlates 
with age, sex, preoperative level of pain and function, number and types of comorbidity, 
site of arthroplasty, body mass index (BMI), self-efficacy, patient perceptions concerning 
the outcome of surgery and muscle strength (unadjusted models)  11, 12, 14, 16, 17, 21-23, 31, 35, 36. 
Patient-reported outcomes or PROs is a general term given to self-reports by the 
patient. Within the last 30 years, enhanced assessments such as health-related quality of 
life (HRQoL) and functional outcomes have been used to assess patients’ physical, 
mental and social conditions before and after knee arthroplasty surgery21. Recently, 
patient satisfaction forms have also been used, as it has been recognized that surgical 
success depends on the patient’s overall level of satisfaction. Today, there are many 
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HRQoL evaluation tools to allow health researchers to measure patient health in a 
standardized fashion. Clinically, one method of measuring functional outcome is through 
patient-reported outcomes such as the WOMAC2, 12.  The WOMAC has three domains 
comprising of function, pain and stiffness. In the OJRR, patient-reported outcomes were 
collected through WOMAC and postoperative patient satisfaction 8.  
 
1.8 - Variables of interest for this study 
Preoperative predictors of functional recovery are important for patients, 
physicians and therapists. Based on a literature review of several studies, we have 
provided a list of variables of interest that have been studied for their association with 
functional recovery: age, sex, BMI, dependency for activities of daily living (ADL), 
living alone status, preoperative WOMAC scores, preoperative comorbidities, site of 
arthroplasty, joint deformities and patient expectations regarding the outcome of surgery 
11, 12, 14, 16, 17, 21-23, 31, 35, 36. Below, these variables will be explained in more detail for their 
significance in knee arthroplasty.  
One important group of variables mentioned above is joint deformities. This term 
refers to any misalignment of the knee joint axes. Many studies have looked at varus and 
valgus knee deformities. As part of their assessments, these studies have also looked at 
increased flexion contracture and reduced flexion range of motion.  The valgus deformity, 
varus deformity, flexion contracture and flexion range of motion will be explained in 
more detail below.  
 
Age  
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Although there is a hesitance to use total knee arthroplasty on very old patients, 
age by itself is not a factor that affects the outcome of surgery and should not be the 
limiting factor when considering who should receive this surgery. Jones et al.21 showed 
that there are no significant age-related differences in WOMAC pain, function or quality 
of life measure pre-operatively or post-operatively (6 months). This study also pointed 
out that older patients are more likely to live alone and to be transferred to a rehabilitation 
facility. In addition, older patients are more likely to have more pre-operative 
comorbidities and depend on others for activities of daily living. Although age alone is 
not associated with changes in WOMAC score, some studies 8,9 have chosen to control for 
age when there were age-related independent variables in their regression model. It is 
even more important to control for age when there is a high variance in the patient age 
distribution.   Therefore, in our study, we included age as a covariate. The age of the 
patient was recorded on the day of the surgery.  
 
Body mass index (BMI) 
Body mass index (BMI) is defined as the individual’s weight (kg) divided by the 
square of his or her height (m2). The universal classifications of BMI are as follows 
ranging from lowest to highest: underweight (<18.5 kg/m2), normal weight (18.5 – 25 
kg/m2), overweight (25-30 kg/m2), obese class 1 (30-35 kg/m2), obese class 2 (35-40 
kg/m2), obese class 3 (over 40 kg/m2). Although there is a strong relationship between 
obesity and rate of usage of total knee arthroplasty as a measure of OA, many studies 
such as Wendelboe et al.35 suggest that there is no evidence of higher risks for knee 
revision procedures based on obesity (by itself). The literature shows more obese patients 
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receive the same benefit (i.e. change from surgery); but the absolute levels of self-
reported function are lower pre-operatively and lower post-operatively, compared to those 
with lower BMI. Wendelboe et al.35 suggest that maintaining ideal weight may prevent 
knee replacement due to OA. The BMI of the patient was captured on our study. The 
weight and height of the patient was recorded on the day of the surgery, for the 
calculation of the BMI.  
 
Gender differences 
According to the work of Kennedy et al. 24, there are substantial pre-operative 
differences between men and women. Using functional measures such as the fast self-
paced walk-test, stair climbing, timed up and go, and self-reported measures, Kennedy et 
al. 24, demonstrated that women showed greater disability than men in physical 
performance and self-report measures. The works of Ethgen et al. 13 showed that age was 
not an obstacle to effective surgery as compared to gender. This team reported that men 
benefited more from intervention than did women. Other studies18, 26 show that there are 
differences between men and women in physical function and pain, where women 
received significant improvement (relative to pre-operative state) in pain scores. 
Interestingly, using the Arthritis Impact Measurement Scale (AIMS), Brodie and 
Sloman10 showed that men were more mobile than women before and after surgery. 
Perhaps this explains the finding that male participants have greater post-operative 
WOMAC scores (absolute scores) after surgery with regard to social function, physical 
function and pain scores, compared to females 18, 24, 26. Furthermore, Kennedy et al. 24 have 
shown that men scored slightly higher in their pre-operative WOMAC assessment, than 
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women. This is related to the finding that men are less likely to delay their knee 
replacement surgery. In our study, the gender of the patient was recorded on the decision 
day for surgery.  
 
Activities of daily living (ADL)  
Muscle atrophy in patients with OA due to long periods of inactivity is an 
important factor affecting post-operative functional recovery after TKA. Some studies 
suggest that this strength deficit can persist after knee replacement 3, 19. Muscle atrophy 
and worsening muscle strength renders late stage OA patients incapable of accomplishing 
activities of daily living on their own. To measure capability of performing ADL, the 
OJRR created a dependency variable that was measured pre-operatively. If the patient 
checked the dependency box, it meant that the patient was not able to accomplish ADL on 
his or her own. 
 
Living alone status 
Gandhi et al.17 has shown that patients who live alone are more likely to delay 
their knee replacement surgery until an older age. Therefore, they are more likely to have 
greater joint pain and dysfunction than those who live with someone else, at the time of 
the surgery. Since pre-operative WOMAC is predictive of postoperative outcomes, these 
patients are more likely to have poorer one-year outcomes after surgery. This makes 
living alone status an important pre-operative predictor of the surgical outcome. The 
OJRR captured this status pre-operatively.  
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Patient expectations 
Patient expectations are important predictors of post-operative satisfaction9. In our 
study, the expectation variable is measured post-operatively. There are three parts to the 
expectation variable. The first part is to assess whether the patient had any expectations 
going into the surgery. Then, if the patient did have any expectations, were they met? 
Expectations met or not met are known to correlate with patient satisfaction. The patient 
also had the opportunity to indicate after the surgery, looking back retrospectively, 
whether their expectations going to the surgery were too high, just right or too low. 
Patient’s judgment of their pre-operative expectations is important, as patients with very 
high expectations were more susceptible to not having their expectations met after the 
surgery. Patients should be advised to have realistic expectations going into surgery, 
based on their pre-operative diagnostics 27.  
 
Pre-operative comorbidities  
One method of quantifying preoperative comorbidities is the  American Society of 
Anesthesiologists (ASA) physical status classification system. In Ontario, 
anesthesiologists routinely record this value in the patient’s surgical records because the 
value recorded impacts their remuneration. This classification system is designed for 
assessing the well-being or pre-operative health of the patient. In our study, this was 
captured as a four-category variable. Category one corresponds to a patient with normal 
health. Category two is a patient with mild systemic disease. Category three is a patient 
with severe systemic disease. The fourth category is a patient with severe systemic 
disease that is a constant threat to life. To ensure proper comparison between the groups, 
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this four-category variable can be collapsed into two categories. The first broad category 
included patients that were normal or had mild systemic disease. The second broad 
category included patients that either had manageable systemic disease or life-threatening 
systemic disease. The ASA status of the patient was recorded on the day of surgery by the 
attending anesthesiologist.  
 
Method of fixation  
In an arthritic knee, the ligaments that are normally responsible for holding the 
bones in place can become damaged or scarred. During total knee replacement surgery, 
the surgeon can choose to substitute or replace some of these ligaments and/or the 
surfaces of the joint. In TKA surgery there are two main methods of fixating the 
prosthetic implant components. The surgeon can either use cementless fixation or a 
cemented fixation method.  
For the cementless fixation method, implants are attached directly to bone without 
the use of cement. These implants have surface topography that attracts new bone growth. 
The surgeon may also use screws to stabilize the implant until bone ingrowth occurs. The 
problem with cementless implants is that they have not solved the problems of wear and 
bone loss. The main problem is that the metal alloy rubs against the ultra high-density 
polyethylene. Sometimes the loads and stress of the daily movements will cause release 
of microscopic particle debris. This debris has been reported to trigger an inflammatory 
response that results in osteolysis. In osteolysis, the bone matrix is resorbed in some cases 
leading to implant loosening or bone breakage, which are serious complications for the 
patient.  
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Most patients receiving TKAs in the OJRR received cemented fixation. For the 
cemented fixation method, the surgeon uses fast curing bone cement 
(polymethylmethacrylate) to hold the prostheses in place.  The cemented fixation method 
has a good durability track record (greater than 20 years). The durability of the implant is 
dependent on activity level, general health and the weight of the patient. “Cemented 
components” is a variable that is measured intra-operatively. Figure 1.11 shows the three 
components that can be cemented for the prosthesis.  
For most patients, all three components will be cemented. But in a number of 
patients, some components will not be cemented. For example in a hybrid fixation 
method, the femoral component is inserted without the cement, while the tibial and 
patellar components are cemented. The OJRR captured all the components that were 
cemented on the day of surgery. 
 
Total knee design  
This is a five category variable. This variable indicates what type of design was 
used to retain or sacrifice the PCL. For retaining the PCL two designs were used: 
retaining standard and retaining medial pivot. The retaining standard design is the more 
preferred design among surgeons. For the PCL sacrificing prosthesis there are three 
designs: sacrificing constrained, sacrificed deep dish and sacrificed post cam. Among the 
PCL sacrificing designs, the sacrificed post cam design is the more preferred design 
among the surgeons23. As with the PCL prosthesis design (retain versus sacrifice), the 
total knee design variable is also based on surgical preference. The total knee design was 
captured in the OJRR on the day of surgery.  
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Figure 1.11 – Cement fixated knee.  This is a depiction of a knee joint, following total 
knee arthroplasty, in which all three components are inserted with cement. The three 
components of the knee joint are the femoral component, the tibial component and the 
patellar component. TKA removes the damaged areas of the femur and tibia, by cutting 
the damaged portions of the bone and cartilage. The ends of the bones are reshaped to 
allow a metal component to fit in place. These parts are then replaced with specifically 
designed metal parts. Note that the metal component is attached to the end of the bone via 
the bone cement. In particular, for the tibial component, a polyethylene insert is attached 
of the metal component. This is to support the body’s weight and allow smooth gliding of 
the femur over the tibia. The tibia component with its polyethylene surface and the femur 
with its new metal component are put together to form the new knee joint. In this case, 
the patella is resurfaced and prepared to receive a polyethylene plastic component. The 
component is cemented into place. This is to ensure that the patella glides smoothly over 
the new artificial knee. This diagram was adapted from 2011 Nucleus Medical Media, 
with permission F-160.  
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Joint deformity 
The main joint deformities in total knee arthroplasties are valgus and varus joint 
deformities. A valgus knee is when there is an outward angulation at the knee or the foot 
appears lateral to vertical axis of the leg. The varus knee is when there is an inward 
angulation at the knee or the foot appears medial to the vertical axis of the leg. Patients 
with either of the deformity may also experience wither flexion contracture or reduced 
flexion range of motion. Flexion contracture is when the knee cannot be fully extended. 
Reduced flexion range of motion is when the patient can fully bend their knee. These 
characteristics cause reduced mobility and make it more difficult for the patient to 
perform activities of daily living. These deformities will be discussed in more detail 
below. Typically, with large joint deformities, it is more difficult to achieve the desirable 
postoperative outcomes36. 
 
Valgus joint deformity  
To optimize the position of the components, it is critical to understand the specific 
pathologic anatomy associated with the valgus knee. As seen in Figure 1.12, a valgus 
deformity is when there is an outward angulation of the distal part of the joint 36. A valgus 
knee deformity arises when the tibia is angled outwards relative to the femur. The valgus 
knee deformity is not as common as the varus knee deformity 36. The valgus joint 
deformity and its severity were captured in the OJRR on the decision day for the surgery. 
To measure the valgus or varus joint deformity, first the center of the knee and the center 
of the femoral head are located on an X-ray image. Then a line is drawn connecting these 
two points.  
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Figure 1.12 - Anterior view of the left knee with a valgus deformity. This is a 
schematic diagram comparing a normal knee (in the left) to a knee with a valgus 
deformity (on the right). In the depiction of the valgus deformity shown on the right, there 
is an overall deformity of 15 degrees. The femoral joint angle is 81 degrees and the tibial 
joint angle is 96 degrees. Normally the femoral joint angle is 87 degrees. Since this knee 
has a femoral joint angle of 81 degrees, the valgus deformity at the femur is 6 degrees. In 
addition, since the normal tibial joint angle is 87 and this knee has a tibial joint angle of 
96 degrees, the valgus deformity at the tibia is 9 degrees. Therefore the overall valgus 
deformity of this knee is 9+6 = 15 degrees. This diagram was adapted from the 
measurement and analysis of axial deformity at the knee with permission F-163 from Dr. 
Kenneth A. Krackow, 2008. 
M	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Next, the center of the ankle is located on the image. Once these points have been 
drawn, then the center of the knee to the center of the ankle is connected via a straight 
line. At this point, there should be two lines: one connecting the head of the femur to the 
center of the knee and another line connecting the center of the knee to the center of the 
ankle. To test for deformity, the angle between these two lines is measured. If the angle is 
180 degrees, this implies no deformity. If the foot is medial (M) to this axis, then there is 
a varus deformity. If the foot is lateral (L) to this axis, then there is a valgus deformity. 
 
Varus joint deformity  
A varus deformity is a classification for patients with an inward angulation of the 
joint 36. As seen in Figure 1.13, in the varus knee, the tibia is turned inward in relation to 
the femur 36. Ligament balancing of a deformed knee is extremely important for the 
success of the knee replacement 36. Particularly, load transfer through a correctly aligned 
and balanced knee will optimize the durability of the knee prosthesis and minimize 
polyethylene wear.  The varus knee deformity is far more common than the valgus knee 
deformity. The varus deformity variable was captured in the OJRR on the day of surgery.  
In one study, Poilvache et al.79 reported in their cohort of 100 patients undergoing 
TKA, there were 54 women in this study. Ten of the eleven patients with valgus 
deformity in this study were women. Poilvache et al. 79  reported an anatomic difference 
that the trochlear groove was angled slightly external relative to the epicondylar line in 
women. Although the higher incidence of valgus in female patients did not fully explain 
this difference, the knee surgeon is more likely to use a PCL sacrificing prosthesis with 
patients that have the valgus deformity. 
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Figure 1.13 – Anterior view of the left knee with a varus deformity. This is a 
schematic diagram comparing a normal knee (on the left) to a knee with varus knee 
deformity (on the right). The varus knee has an overall varus deformity of 14 degrees. In 
this knee the femoral joint angle is 102 degrees. Since the normal femoral joint angle is 
87 degrees there is varus deformity of 14 degrees in the femur. The tibial joint angle is 88 
degrees. Since the normal tibial joint angle is 87 degrees there is actually a valgus 
deformity of 1 degree. Therefore there is 15 degrees varus and 1 degree valgus, leading to 
an overall varus deformity of 15 – 1 = 14 degrees. This diagram was adapted from the 
measurement and analysis of axial deformity at the knee with permission F-163 from Dr. 
Kenneth A. Krackow, 2008. 
M	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Flexion range of motion  
In late stage OA patients, there is a limited range of motion in which the joint has 
a reduced ability to move. There are a number of reasons behind limited range of motion, 
which can include pain, stiffness, swelling, injury or deformity of the knee joint. The 
flexion range of motion was captured on the decision day for surgery. Pre-operative 
flexion range of motion (ROM) is one of the strongest predictors of the postoperative 
flexion ROM regardless of the preoperative alignment (varus or valgus) 32. As seen in 
Figure 1.14, the best flexion range of motion is greater than 155 degrees or when the 
patient can touch the heel of their foot to their buttocks (maximum flexion). A value of 
greater than 90 degrees is desirable for the patient. A normal flexion range of motion is 
135-150 degrees of flexion. There are three ways of measuring the range of motion. 
Passive range of motion assessment requires the therapist to move the joint through the 
ROM without any effort from the patient. The active assistive ROM requires the patient 
to use the muscles surrounding the knee joint to do a specific exercise while some 
assistance is received from the therapist. The most common preoperative assessment is 
active ROM, when the patient performs a specific ROM exercise without any support.  
Although controversial, some studies have pointed out that PCL sacrificing 
provides better post-operative flexion ROM than the PCL retaining prosthesis74. The 
surgical technique is also important to achieve better post-operative ROM74. For example 
some of these techniques include tightness of the PCL (if retained), the elevation of the 
joint line and increased patellar thickness74. That is to say, with vigorous rehabilitation 
(with physiotherapist) after the surgery, along with passive motion exercises, the patient 
can help improve their post-operative flexion range of motion74. 
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Figure 1.14 - Schematic diagram of knee flexion range of motion. When the knee is 
fully extended, there is zero angle of flexion. The best knee flexion is achieved at an 
angle greater than 155 degrees or when the heel of the foot can touch the buttocks. 
Although full flexion is desirable, a flexion of or greater than 90 degrees is also desirable 
in patients receiving total knee arthroplasty. This diagram was adapted from © 2012 
Zimmer, Inc. education brochure with permission F-164.   
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Flexion Contracture  
Knee flexion contracture is the inability of the knee to fully extend due to pain 
and/or stiffness. In many cases, a knee that doesn’t fully extend will be more likely to not 
achieve full strength, and may continue to be painful and swollen. In a typical knee 
replacement sample population, there will be a small percentage of patients that have 
knee flexion contracture. In those that do have flexion contracture, it will be marked 
whether the contracture is less than 15 degrees or more. For example, figure 1.15 shows a 
schematic diagram of a knee with 25 degrees of flexion contracture. This means that the 
patient can only extend their knee up to 155 degrees. This is 25 degrees short of full (180 
degrees) extension. The preoperative flexion contracture of the patient may predict the 
postoperative functional outcome 44. Although TKAs can correct for knee flexion 
contracture, it is usually more difficult to achieve better postoperative results with 
patients that have higher than 15 degrees of preoperative flexion contracture 44. The 
flexion contracture and its severity were measured preoperatively on the decision day for 
the surgery.  
 
Postoperative complications  
After any surgery, there is always the possibility of postsurgical complications. 
Some immediate complications that were captured in our study were dislocation of the 
prosthesis, blood clot formation, pneumonia, infection and fracture. As part of patient 
post surgery self-assessment, the patient was given the chance to point out any 
complications that may have arisen since the surgery.  
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Figure 1.15 – Depiction of knee flexion contracture. Flexion contracture of the knee 
exists when there is an inability to fully extend the knee. A fully extended knee is said to 
have zero degrees of flexion contracture. Any deviation is measured from the zero degree 
of flexion contracture.  For example, if a patient can only extend their knee up to 155 
degrees, it is reported that the patient has 25 degrees (180-155 = 25°) of flexion 
contracture.  
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These post-operative complications can also affect the self-reported WOMAC 
scores. This is evident as some patients end up with negative WOMAC change scores. 
This means that their postsurgical physical state was worse than before the surgery.  The 
postoperative complications were recorded from patient records at the one-year follow-up 
date. For the full follow-up questionnaire please refer to appendix C. 
 
Waiting time for surgery 
 There was one variable that was included relevant to waiting time for surgery. 
This was the “surgery sooner” variable, in which the patient could mark down whether 
they would have preferred to have the surgery earlier. Although some patients were given 
the green light to have the surgery, some chose to delay the surgery to perhaps consult 
with another surgeon or for other personal reasons. Figure 1.16 summarizes the time-line 
from the time the patient decides to consult a physician to the follow-up date one year 
after the surgery.  
 
Good outcomes are more likely to be achieved when the surgery is done soon 
(within a few months) after the decision for surgery. Some studies reported that patients, 
who have a lower preoperative WOMAC score, achieve lower absolute postoperative 
WOMAC scores than those with better preoperative scores 11.That is to say, patients with 
lower pre-operative scores are more likely to experience more change in their scores.  
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Figure 1.16 - Path taken by the patient from the decision for surgery to the one-year 
follow-up point. In phase A, the patient is waiting for an appointment with his or her 
family physician. Several factors can affect this waiting time. These include access and 
availability of the general physician9. In phase B, the patient has been consulting his or 
her family physician and is ordered medical tests. At this point the patient is waiting to 
see an orthopaedic surgeon for the knee. Several factors can influence this waiting time, 
including the availability of the surgeon, the surgeon’s capability to take new patients and 
the severity of the reported medical diagnostics9. In phase C, the patient has been seen by 
a surgeon and is considering their options. More tests may be required. At this point of 
time, several factors may influence the time taken for the patient to finalize their decision. 
These factors include the patient’s willingness (or fear) to undergo surgery, their opinion 
of the surgeon, the complexity of the procedure, the total costs and benefits of the surgery 
and, lastly, the availability of non-surgical alternatives9. Once the patient makes the 
decision to have the surgery, the patient enters phase D. In here, the patient and surgeon 
wait for the availability of operating rooms in the hospital. This wait time can range from 
3-24 months! This period is influenced by many factors including the surgeon’s 
preference for different surgical procedures23, the hospital operating room resources, the 
priority of the patient (based on the severity) and lastly the number of surgeries assigned 
to the surgeon. Phase E represents a one-year post-operative recovery. On the follow-up, 
the patient revisits the surgeon and provides postoperative WOMAC and satisfaction 
forms. Phase F represents the temporal variability in the one year follow-up.  
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Baseline severity (preoperative WOMAC scores) 
Ideally, patients with a low WOMAC score (i.e. < 30/100) should be admitted to 
surgery within three months after the decision time9. This is not always the case for 
several reasons such as availability and accessibility issues 9. It is more difficult to 
achieve a desired functional outcome after the surgery, when the patient has poor 
preoperative functional status 11. While lower preoperative scores provide more potential 
for higher change score, it does not guarantee a desired postoperative functional score. In 
fact, the lower the preoperative scores, the more likely the postoperative score will be 
lower compared to patients that have a higher preoperative score9.  
 
1.9 – Rationale for the thesis study 
In general with aging, it is well established that women are more likely to develop 
autoimmune diseases, patella-femoral arthritis, valgus deformity of the knee, osteoporosis 
and most importantly degenerative osteoarthritis64. Hence, women on average represent 
60% of total knee arthroplasty surgical candidates64. There are several studies that have 
already shown that, at the time of the surgery, women tend to have a higher degree of 
disability, present worse symptoms and were less willing to have the TKA65-69. Since it is 
well known that lower pre-operative WOMAC scores are associated with lower post-
operative WOMAC scores, this shows that gender can have an impact on patient-reported 
outcomes. Also, this is an indication that women deal with osteoarthritis differently than 
men64.  
In addition, a study by Chin et al. 70 by using a cohort of 100 men and 100 women 
showed that for any given anterior-posterior femoral dimension, the women had a 
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narrower medial-lateral measurement than men. Hitt et al. 71 also compared 6 prosthetic 
design dimensions and concluded that in women, there was a significant association 
between the femoral component size and the amount of overhang, where the women with 
larger femurs had more overhang. The problem with femoral implant overhang is that it 
can cause soft tissue irritation, patella-femoral stress and soft tissue balance problems. 
Mahoney et al. 72 confirmed these results where they showed in their multivariate analysis 
that component overhang could cause up to two-fold increase in post-operative pain for 
women. These results may suggest that part of the differences in WOMAC pain scores 
are due to an association between gender and prosthetic design.  
Prosthetic designs for the use in primary TKA allow for preservation of the PCL 
(cruciate-retaining/PCL retaining), or sacrifice of the PCL (PCL sacrificing) 1, 10, 23. Both 
options have advantages and disadvantages23. Some studies that looked at physiological 
differences between men and women found that women are more likely to develop 
ligament laxity and have different stiffness in the soft tissue in their osteoarthritic knee 
when compared to men64. This becomes important, when the surgeon has to choose 
whether to retain or sacrifice the PCL. If the PCL is damaged or is not fully functioning, 
the surgeon is more likely to sacrifice the PCL and use a PCL-sacrificing prosthesis. The 
gender difference in ligament laxity, soft tissue stiffness and functioning ligaments 
surrounding the knee joint, might suggest that there can be an interaction between gender 
and PCL prosthesis design at the time of the surgery.  
Whether the PCL is retained or sacrificed, the implants used have specific 
geometry to account for the presence or absence of the PCL. Many studies have 
compared the PCL prosthesis design by using patient-reported outcomes for measuring 
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health-related quality of life (HRQoL) 1, 25, 33. Even though both sides present valid 
arguments, some studies that compared the two procedures have concluded that there are 
no significant differences in patient-reported outcomes regardless of whether the PCL is 
retained or sacrificed. 51 That is to say, the impact of PCL prosthesis design on WOMAC 
change scores has remained a controversial area of research for the past two decades.  
While WOMAC change scores allow knee surgeons to look for changes in pain, 
stiffness and function of the knee joint, it is necessary to include a more direct way of 
measuring patient satisfaction. On average, only 82-89% of patients receiving TKAs are 
satisfied with their results8. After all, the success of the surgery is dependent on the 
satisfaction of the patient after the surgery. Another important reason to include a 
satisfaction component is to test whether the gender differences observed are 
physiological or disease specific. If men and women differ in their satisfaction ratings, it 
may suggest that the differences seen in patient-reported outcomes are gender-specific. In 
other words, it may be that, as with other diseases, men and women deal with the disease 
and intervention differently and thus give different satisfaction ratings. This may explain 
why we haven’t seen drastic improvements in HRQoL, even after the implementation of 
gender-specific implants, which account for genders-specific anatomic and gait 
differences.  
Post-operative patient satisfaction can be affected by multiple factors. It is well 
established that postoperative complications can affect patient satisfaction8. There are 
multiple gender-specific factors that can cause postoperative complications. For example, 
ligament size, knee laxity, limb alignment and knee notch dimensions have been said to 
put women at a higher risk for ACL injury73. Since ligament laxity and limb alignment are 
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factors surgeons take into consideration when choosing to retain or sacrifice the PCL, 
perhaps post-operative patient satisfaction can also be affected by the interaction of the 
gender of the patient and the prosthetic design (retain vs. sacrifice).  
To the best of our knowledge, there is no large-scale study that has looked at the 
interaction between the gender of the patient and PCL prosthesis design. While there is 
very little debate that gender differences exist in total knee arthroplasty outcomes, the 
decision to retain or sacrifice the PCL is highly debated by the orthopaedic community. 
Since there is little doubt that gender differences exist, it is important to ask whether there 
is an interaction between gender and PCL prosthesis design. That is to say, the interaction 
of gender with PCL prosthesis design on patient-reported outcomes is still unclear.  
 
1.10 - Objectives 
Our primary objective was to investigate whether the interaction between gender 
and PCL prosthesis design impacts (i) WOMAC change scores and (ii) patient 
satisfaction. If a significant interaction exists, it would mean that gender differences 
should be considered in the delivery of outcomes. An extra step is required to determine 
clinical implications that may arise from this relationship. It would have to be determined 
whether men or women would benefit from a specific PCL prosthesis design. For 
example, would women achieve higher WOMAC change scores and better satisfaction if 
they receive a PCL retaining prosthesis, as opposed to the PCL sacrificing prosthesis? 
The same question would apply to men. We used the Ontario Joint Replacement Registry 
data to achieve this objective.  
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1.11 - Hypothesis 
We hypothesized that the interaction between gender and PCL prosthesis design 
impacts WOMAC change scores and patient satisfaction in patients receiving primary 
unilateral TKAs. In particular, females with PCL sacrificing design will report better 
WOMAC change scores and higher postsurgical patient satisfaction than males.   
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2.1 - Research Design 
This study is a historical analysis of prospectively collected data in a provincial 
database called the OJRR, which is now part of a larger Canadian joint replacement 
registry (CJRR). The purpose of both the OJRR and the CJRR were to provide annual 
reports that present characteristics of the epidemiology of total knee replacements and 
total hip replacements 4, 9. For this study, we used data from total knee replacement 
surgeries collected through the OJRR. These data were obtained from Ontario surgeons 
participating in the OJRR 4, 9. By using the data from the OJRR we assess relationships 
between our predictor variables and our outcome variables, and thereby help create 
evidence-based tools to help improve decision-making regarding controversial issues.  
The ultimate goal of the OJRR was to provide data that can be used to improve the 
quality of care and clinical outcomes for patients receiving total joint replacements 4, 9. 
The OJRR was funded by the Ontario Ministry of Health and Long Term Care 
(MOHLTC). In April 2006, the MOHLTC transitioned the operations of the OJRR to the 
CJRR.  During this transfer, the MOHLTC approved the creation of a de-identified 
version of the transferred database which could be housed at the London Health Sciences 
Centre (LHSC) for research purposes.  Therefore, the OJRR data used for this thesis was 
accessed from LHSC. The data used for this study was collected between 2001 and 2006. 
The Research Ethics Board of Western University and Lawson Health Research Institute 
approved the study. The research ethics board approval is provided in appendix A. 
Patients who participated in the OJRR were followed in time from the decision to 
proceed with knee replacement surgery, through the surgical event to the one-year follow-
up after their surgery. Along with surgical and clinical data elements, the OJRR collected 
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two important subsets of information: wait times for surgery and pre/post-operative 
functional status scores 4, 9.  
 In order for the OJRR data to be transferred to the CJRR, before any subset of 
data was provided, a mapping exercise was conducted between the OJRR and the CJRR 
database components to ensure compatibility 4, 9. For example, for some components, the 
OJRR had a higher level of detail in data elements when compared to the CJRR. In this 
scenario, the extra data from the OJRR was captured in the “other” category or sometimes 
it was retained in the CJRR database as additional data elements. In addition to these 
mapping exercises, the OJRR database was also subjected to edit checks by the Canadian 
Institute of Health Information (CIHI), in order to identify errors such as out of range 
values and problems with the data logic 4, 9. These edits have to be performed on raw data 
before entry to the much larger CJRR database.  
 
2.1.1 - Inclusion Criteria  
Patients who received a primary unilateral total knee replacement and who 
consented to have their data shared with the OJRR were included in the dataset used for 
the current study.  
 
2.1.2 - Exclusion Criteria 
Patients who received a revision knee arthroplasty, or a second primary knee joint 
replacement subsequent to the index event but before the one-year follow-up for that 
index surgery. Also patients who reported their employment status as ‘on disability’ were 
excluded from this study.  
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2.2 - Preoperative assessment  
This assessment was done on the decision date for surgery. At this point, the 
WOMAC disability questionnaire was used to capture the baseline severity of the patient. 
Living situation as well as social factors were measured by determining if the patient 
lived alone (yes/no), if they were dependent on someone else for activities of daily living 
(ADL) (yes/no), if others were dependent on them for their ADL (yes/no), hereafter 
referred to as caregiver status, and their employment status (employed, not employed). 
Several other important variables such as referral date, decision date for surgery and the 
date of surgery were also recorded to determine the waiting time for surgery. 
 
2.3 - Intraoperative assessment 
This assessment was done on the day of the surgery at the hospital. The following 
variables were recorded at the time of surgery: age, gender, weight and height for body 
mass index calculation (BMI) in Kg/m2, surgical joint, pre-operative joint status and 
primary diagnosis of the surgical joint and comorbidities. As part of the preoperative joint 
status, the involved knee was assessed for any joint deformities. There were 3 categories 
of joint deformity for the involved knee: varus knee deformity, valgus knee deformity and 
flexion contracture. To classify the varus knee deformity, there were three subcategories 
used: None, varus deformity angle ≤15° and varus deformity angle >15°. Similarly, for 
the valgus knee deformity, there were also three subcategories used: None, valgus 
deformity angle ≤15° and valgus deformity angle >15°. Also, for flexion contracture three 
subcategories were used: None, flexion contracture angle ≤15° and flexion contracture 
angle >15°. The last part of the assessment for preoperative joint status included an 
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assessment of knee flexion range of motion (ROM) and the results were classified under 
two subcategories: flexion ROM angle < 90° OR flexion ROM angle > 90°.    
For primary diagnosis the most responsible diagnosis for the knee was recorded 
from the following choices: degenerative osteoarthritis, inflammatory arthritis, 
posttraumatic osteoarthritis, osteonecrosis, infection, tumour, acute fracture or other.  
For the assessment of preoperative physical health comorbidity, two proxy 
variables were used: the American Society of Anaesthesiologists Physical Status Score 
(ASA) and the Charnley category were measured at this time point 4, 9. For this study, the 
ASA was used to classify the preoperative physical health of the patient. In our study, this 
was captured as a four-category variable. The anesthesiologist assigns these values to the 
patient. Category one means that the patient had normal health. Category two is a patient 
with mild systemic disease. Category three is a patient with severe systemic disease. 
Category four is a patient with severe systemic disease that is life threatening. In order for 
us to properly compare the groups, we collapsed this four-category variable into two 
categories. The first broad category included patients that were normal or had mild 
systemic disease. The second broad category included patients that either had manageable 
systemic disease or life-threatening systemic disease. The ASA status of the patient was 
recorded on the decision day for surgery 4, 9.  
The hospital teaching status was also recorded (teaching/non-teaching) 4, 9. Also, if 
for any reason the surgery was delayed, this was also recorded. Some possible reasons 
could have been health care related (ex. lack of hospital beds), patient medical status 
requiring surgical delay, or simply patient preference to delay the surgery. Other surgical 
information such as the prosthetic device details and the total knee designs were also 
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recorded. In patients with a functional PCL, the decision on which design is chosen 
depends largely on the preference of the surgeon. In either case, the implants used have 
specific geometry to account for the presence or absence of the ligament. For retaining 
the PCL two designs were used: retaining standard and retaining medial pivot. For the 
PCL sacrificing prosthesis there were three designs: sacrificing constrained, sacrificed 
deep dish and sacrificed post cam. Both the PCL prosthesis design variable and total knee 
design variable were measured on the surgery day.  
 
2.4 - Postoperative assessment 
One year after surgery, a questionnaire was sent to patients by mail to measure the 
outcome of the surgery using the WOMAC disability questionnaire. The logistics of large 
volume mail-outs meant that this data capture time point took place between 12 and 18 
months after the surgery. As indicated before, the WOMAC questionnaire provides 
standardized scores for pain, joint stiffness and function. In addition, the survey 
questionnaire package also included a section to measure patient satisfaction. The patients 
were asked to rate their overall satisfaction on a 5 point likert scale with the following 
options: very satisfied, satisfied, neutral, dissatisfied and very dissatisfied. In addition 
patients were also asked whether the results of the surgery met their expectations (yes, no, 
I had no expectations), whether the patient felt that the waiting time for the surgery was 
acceptable (yes, no, not sure) and an indication of whether or not the patient would still 
have had the surgery if he or she could go back in time (yes, no, uncertain).  
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2.5 - Entire Experimental group 
This study analyzed prospectively collected data from the Ontario Joint 
Arthroplasty Registry obtained between 2001 and 2006. The Research Ethics Board of 
Western University and Lawson Health Research Institute approved the study. The 
research ethics board approval in provided in appendix A. Variables from the database are 
summarized in Table 2.1. The preoperative, demographic and intraoperative variables 
were recorded on surgery-specific forms, provided in appendix B.  Functional status was 
measured with the WOMAC Disability Questionnaire6.  The patient baseline severity was 
captured at the decision date for surgery, using the WOMAC6. Patients were followed for 
one-year post- surgery. Patients were sent a mailed survey that included the WOMAC, 
self-reported complications requiring hospital admission, a satisfaction rating, and a 
judgement about whether or not expectations of surgery had been met.  
 
2.6 – Dependent variables of interest 
 There were two dependent variables of interest in this study. The first dependent 
variable was the WOMAC change score which was calculated by obtaining the difference 
between the post-operative WOMAC score and the pre-operative WOMAC score. The 
second dependent variable was the patient satisfaction variable which was measured 
based on a 5 point likert scale.  
 
2.7 - Self-Assessment Questionnaires 
All WOMAC scores were reversed and standardized to a score from 0 to 100 
where 0 is the worst and 100 is the best state.  
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Table 2.1: Summary of data collected as a function of time. This table condenses all 
the data collected for the Ontario Joint Replacement Registry at the three time points for 
data capture. The WOMAC was collected twice9. The first time the WOMAC was 
collected was at the decision time for surgery (baseline value) and the second one was 
collected at the one year following the surgery. The patient satisfaction form was also 
collected at the one-year follow-up point.  
 
Capture 
point 
Activities Data Collected 
Decision 
time for 
Surgery 
• Patients recruited for 
primary unilateral 
knee replacements 
were recruited  
• Preoperative data was 
collected at this point 
• Decision date for the surgery was 
recorded 
• The WOMAC osteoarthritis 
disability Index was used to 
measure the preoperative 
(baseline) severity.  
• Patient specific characteristics 
were recorded at this time, 
including their living status, 
dependency for ADL and ASA 
scores. 
Surgery 
day 
• Medical and surgical 
data was collected.  
• Surgery date marks the end of 
waiting time for the patient 
• Surgery specific data such as 
Medical and prosthesis 
information were recorded at this 
time-point 
One year 
follow-up 
date 
• This marks the end of 
the observation period 
and the one-year post-
operative data was 
collected at this point. 
• The WOMAC osteoarthritis 
disability index was administered 
at the one year follow-up date 
• Patient satisfaction, patient 
expectations met, were also 
recorded. 
• Change in pain and function 
(Follow-up scores – baseline 
scores) were recorded through 
self-reported outcomes.  
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We used WOMAC change scores as our measurement of functional outcome from 
surgery13. The WOMAC change score was the difference between the one-year follow-up 
and baseline WOMAC. Positive scores indicate improvement after surgery.  
Patients were also asked to rate their overall satisfaction with the result of the joint 
arthroplasty, using a five-point scale with the following response choices: very satisfied, 
satisfied, neutral, dissatisfied, and very dissatisfied27, 45. The follow-up surgery allowed 
for recording of postoperative complications, pain, function, satisfaction, change in pain 
and change in function 46. 
 
2.8 - Covariates 
We created an extensive list of literature supported (please see introduction) 
control variables that we used as covariates 5, 8, 13, 16, 17, 47, 48. Our covariates were: age 
(continuous), gender (dichotomous: male=0, female=1), BMI [kg/m2](continuous), lives 
alone (dichotomous: no = 0, yes = 1), dependency for ADL (dichotomous: no = 0, yes = 
1), pre-operative WOMAC total score (continuous), American Society of 
Anesthesiologists Physical classification System [ASA-PS] (dichotomous: 
healthy/mild=0; severe/life threatening=1), valgus knee deformity (categorical: no 
deformity = 0, valgus≤15° =1, valgus>15° =2), varus knee deformity (categorical: no 
deformity = 0, varus≤15° =1, varus>15° =2), flexion contracture (categorical: no 
contracture= 0, contracture≤15° =1, contracture>15° =2), flexion Range of Motion 
[Flexion ROM] (categorical: ROM ≤ 90° = 1, ROM>90° = 0), PCL prosthesis design 
(dichotomous: PCL retaining prosthesis=1, PCL sacrificing prosthesis=2), component 
fixation method (dichotomous: not cemented = 0, cemented = 1) and presence of a post-
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operative complication requiring hospitalization (dichotomous: no  = 0, yes = 1). As part 
of the satisfaction questionnaire several other variables were measured that were included 
in our covariates. The first one is whether the patient would have the surgery again 
[stilldo] (categorical: yes=1, uncertain=0, no= -1) and the second one is would they have 
the surgery earlier if possible [surgery sooner] (categorical: yes=1, uncertain=0, no= -1). 
Our last variable in our model was the interaction term created by the product of gender 
and PCL prosthesis design variables. To study the interaction between gender and PCL 
design, and its influence on function outcome and HRQoL, we created an interaction term 
from the product of gender (male=0 or female=1) and PCL design (dichotomous: PCL 
retaining=1, PCL sacrificing= 2). 
 
2.9 - Dummy variables 
For our 3-level categorical variables we created dummy variables to make sure 
that the different values in those variables have the correct numerical relationship to one 
another. The resultant dummy variables only have two values, zero and one.  For each 
variable there is one level that is coded as a zero (reference category) and this is the 
category to which all other categories were compared. We created dummy variables for 
the following categorical variables: still do, flexion contracture, valgus deformity, varus 
deformity and surgery sooner.  
For the Still do categorical variable, there were two dummy variables (stilldo1 and 
stilldo2). Our reference category (assigned as -1) was = ‘no’. Thus, when the “still do” 
variable had a value of -1 (i.e. no), then both stilldo1 and stilldo2 dummy variables were 
given a value of zero. When our still do variable had a value of 0 (unsure), then our 
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stilldo1 dummy variable was assigned a value of 1 and our still do 2 dummy variable was 
assigned a value of 0.  When our still do variable had a value of +1, then our stilldo1 
dummy variable was assigned a value of 0 and our stilldo2 dummy variable was assigned 
a value of 1. 
For the surgery sooner variable (sx sooner) we also created two new dummy 
variables, surgery sooner 1 and surgery sooner 2. Our reference point was when the 
surgery sooner variable had a value of -1 (no). When our surgery sooner variable had a 
value of zero (uncertain), then our surgery sooner 1 dummy variable was given a value of 
one while our surgery sooner 2 dummy variable was given a value of zero. When our 
surgery sooner variable had a value of +1 (yes) then our surgery sooner dummy 1 variable 
was given a value of zero and our surgery sooner 2 dummy variable was given a value of 
one.  
For the “flexion contracture” variable we also created two dummy variables, 
flexion contracture 1 and flexion contracture 2. Our reference point was when flexion 
contracture had a value of zero (no contracture). When flexion contracture had a value of 
zero, both flexion contracture 1 and 2 dummy variables were assigned a value of zero. 
When flexion contracture had a value of one, our flexion contracture 1 dummy variable 
was assigned a value of one while our flexion contracture 2 dummy variable was assigned 
a value of zero. When our flexion contracture variable had a value of two, our flexion 
contracture 1 dummy variable was assigned a value of zero, and our flexion contracture 2 
dummy variable was assigned a value of one.  
Both the valgus variable and the varus variable were categorical variables with 
values for each (0 = no deformity, 1 = deformity<15, 2 = deformity >= 15). When making 
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the dummy variables, the two variables were combined to make 4 dummy variables in 
total (Varus Valgus 1, Varus Valgus 2, Varus Valgus 3, Varus Valgus 4).  The varus and 
valgus variables were combined because a patient cannot have both a valgus and a varus 
deformity at the same time. For example a patient can either have no deformity, or have 
various degrees of either the varus deformity or the valgus deformity (not both). Our 
reference category (0) was = ‘no deformity’.  When the patient had a valgus deformity 
less than 15 degrees, the valgus varus deformity 1 dummy variable was given a value of 
one, while the rest were set to zero. When the patient had a valgus deformity greater than 
15 degrees, then the valgus varus 2 dummy variable was given a value of one and the rest 
were set to zero. When the patient had a varus deformity of less than 15 degrees, then 
valgus varus 3 dummy variable was set to one and the rest were set to zero. When the 
patient had a varus deformity of greater than 15 degrees, then the valgus varus 4 dummy 
variable was set to one and the rest were set to zero. This way all the values for both 
valgus and varus variables were combined into four dummy variables. 
 
2.10 - Statistical analysis 
Since gender was of primary importance to our study, we conducted a series of 
analyses between our predictor variables and gender. Descriptive statistics are reported as 
means and standard deviations or frequencies as appropriate. A series of Kolmogorov 
Smirnov tests of our continuous variables indicated a non-normal distribution, 
necessitating the use of a non-parametric test instead, which was either the Wilcoxon 
signed rank test, or the chi-square test.  
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 To understand the relationships we aimed to investigate, we conducted a series of 
univariate and bivariate analyses. Continuous variables were compared using Wilcoxon 
signed rank test. Categorical variables were compared using the chi-square test.  
We then conducted a multivariate regression analysis, which allowed us to 
correlate our predictive variables with functional outcome measured through the HRQoL 
WOMAC change score and patient satisfaction. For each dependent variable (WOMAC 
change score and satisfaction), we initially tested an unadjusted model using gender, PCL 
design and the interaction term. Then we added covariates to test for the presence of an 
interaction in the fully adjusted model.  
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Chapter 3: 
Results 
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3.1 - Preoperative Assessment   
After our exclusion criteria were applied, we retained 989 females and 624 males. 
The primary diagnosis for 96% of our patients was degenerative osteoarthritis. Table 3.1 
is a demographic table summarizing some of the gender differences in our knee 
arthroplasty cohort. On average our patients had a high BMI of 31.4 (±6.1 kg/m2). 
Women, on average, had a significantly (p<0.05) higher BMI than men  (32.24 vs. 30.41, 
respectively). The percentage of patients who depended on someone else for activities of 
daily living (ADL) was statistically different between men and women, where more 
women (21.4%) were dependent than men (12.5%, p<0.05). More women lived alone 
(26.4%) when compared to men (9.1%, p<0.05). The preoperative ASA categories were 
not significantly different between men and women (p>0.05). Overall, 67% of our 
patients had a varus knee deformity and 16% had a valgus deformity. The frequency of 
the varus deformity was significantly different between men and women (p<0.05). 
Similarly, the frequency of men and women with a valgus deformity was also 
significantly different (p<0.05). Our results showed that more women had pre-operative 
flexion contracture (p=0.038). Ninety two percent of our patients had a flexion 
contracture less than 15° and 87% were able to achieve a flexion angle range of motion 
(ROM) of or greater than 90°. Flexion ROM of the knee joint did not differ significantly 
between men and women (p>0.05). Pre-operatively, women reported more stiffness, more 
pain and less function on the WOMAC questionnaire compared to men (p<0.05). 
Similarly, women had a lower pre-operative total WOMAC score compared to men 
(p<0.05).  
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*  p value is significant.  
Joint Demographics Total (n=1613) Female (n=989) Male (n=624) P-value 
Age (Years) 69.5±8.8 69.4±9.0 69.8±8.3 <0.05* 
     
Body Mass 
Index 
(kg/m2) 
Average 
Underweight 
Normal 
Overweight 
Obese 1 
Obese 2 
Obese 3 
31.4±6.1 
0.1% (1) 
8.8% (142) 
33.4% (538) 
31.6% (509) 
14.9% (241) 
11.0% (177) 
32.2 ± 6.7  
0.1% (1) 
8.9% (88) 
30.2% (298) 
28.8% (284) 
17.3% (171) 
14.7% (145) 
30.4± 5.0  
0.0% (0) 
8.7% (54) 
38.6% (240) 
36.2% (225) 
11.3% (70) 
5.2% (32) 
<0.05* 
      
Baseline WOMAC 42.6±15.7 40.8±15.3 45.6±15.9 <0.05* 
     
Follow-up WOMAC 82.0±16.6 81.3±16.6 83.22±16.5 <0.05* 
     
ADL  
Help needed 
No help needed 
 
16.6% (268) 
83.4% (1345)  
 
21.4% (204) 
78.6% (785) 
 
12.5% (64) 
87.5% (560) 
<0.05* 
      
ASA  
 
 
CAT 1 
 
CAT 2 
 
62.6% (1010) 
 
37.4% (603) 
 
 
61.4% (619) 
 
38.5% (370) 
 
59.6 % (372) 
 
40.4 % (252) 
>0.05 
Valgus  
Deformity  
 
 
None 
< 15° 
≥ 15° 
 
 
83.9% (1353) 
10.5% (169) 
5.6% (91) 
 
88.0 % (830)  
7.9 % (104) 
4.1 % (55) 
 
94.6% (590) 
3.7% (23) 
1.8% (11) 
<0.05* 
Varus 
Deformity 
 
 
None 
< 15° 
≥ 15° 
  
 
32.8% (529) 
60.7% (979) 
6.6% (105) 
 
27.8 % (324)  
64.4 % (600) 
7.8 % (65) 
 
20% (125) 
70.2% (438) 
9.8% (61) 
<0.05* 
PCL design  
PCL retained 
PCL sacrificed 
 
52.4% (845) 
47.6%  (768) 
 
51.5% (502) 
48.5% (473) 
 
53.9% (332) 
46.1% (284) 
>0.05 
 
Total knee design 
Retaining medial pivot  
Retaining standard  
Sacrificed constrained 
Sacrificed deep dish  
Sacrificed post cam  
 
 
2.4% (38) 
50.0% (796) 
1.0% (16) 
3.7% (58) 
42.9% (683) 
 
 
2.3% (22) 
49.2% (480) 
1.1 % (11) 
3.1% (30) 
44.3% (432) 
 
 
2.6% (16) 
51.3% (316) 
0.8 % (5) 
4.5 % (28) 
40.7% (251) 
 
>0.05 
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Table 3.1 - Clinical characteristics of the arthroplasty cohort stratified by gender. 
Average values are reported as mean ± standard deviation. The percentage of patients 
in each subcategory is reported as percentage of patients (number of patients). There are 
significant gender differences involved with age, BMI, baseline WOMAC, follow-up 
WOMAC, dependency for ADL, valgus knee deformity and varus knee deformity. Due to 
missing reports, some subcategories do not add up to 100%. For example, the total knee 
design variable suggests that we should have 844 patients receiving PCL retaining 
procedures (38+796) but the PCL design variable tells us that we have 845 patients. It is 
understood that the missing person in the PCL retaining group, has received a PCL 
retaining device but it is uncertain whether it was a retaining medial pivot design or 
retaining standard design.   
 
 
3.2 - Intra-operative assessment 
The tibial base plate was cemented in 99.8% of females and in 100% of men 
(p>0.05). The femoral component was cemented in 87.8% of women as compared to 87% 
of men (p>0.05). The patellar component was cemented in 90.6% of women and 92% of 
men (p>0.05). Lastly, 79% of women and 79.3% of men had all three components 
cemented (p>0.05). 
The PCL was retained in 51.5% of women and 53.9% of men (P>0.05). Overall, 
there were 5 different total knee designs used for the PCL: retaining medial pivot, 
retaining standard, sacrificed constrained, sacrificed deep dish and sacrificed post cam. 
Approximately 43% of the procedures were done using sacrificed post cam and 50% were 
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done using the retaining standard method. The sacrificed post cam design was used in 
44.3% of women and 40.7% of men. The retaining standard design was used in 49.2% of 
women and 51.3% of men. The types of designs used were not significantly different 
between men and women (P>0.05).  
 
3.3 - Postoperative Assessment 
Post-operatively (in the unadjusted model) women still had more pain, more 
stiffness and less function than men, following the surgery (P<0.05). Even though men 
had higher total WOMAC scores than women (P<0.05), women had significantly higher 
total WOMAC change scores than men (P<0.05). Similarly, women had higher change 
scores for pain (P<0.05), stiffness (P<0.05) and function (P<0.05). Only 4.6% of men had 
post-operative complications as compared to 3.8% of women (P>0.05). 
For WOMAC change scores, the following variables were used in our multivariate 
linear regression model: age, gender, BMI, total preoperative WOMAC score, ASA 2 
categories, dependency for ADL, living alone status, cemented components, varus knee 
deformity, valgus knee deformity, flexion contracture, flexion range of motion, PCL 
design, PCL design surgical procedure, wished surgery was sooner (surgery sooner) and 
would still have surgery (still do). As indicated in the methodology, for a selected number 
of our categorical variables we used dummy variables. The variables were: flexion 
contracture (flexion contracture 1 and 2), varus knee deformity and valgus knee deformity 
(varus/valgus deformity 1,2,3 and 4), wished surgery was sooner (surgery sooner 1 and 2) 
and would still have surgery (still do 1 and 2). Table 3.2 shows the result of our 
multivariate analysis using the variables mentioned above as covariates.  
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Table 3.2 – The impact of gender*PCL prosthesis design interaction on WOMAC 
change score. This table shows the results of the multivariate analysis with WOMAC 
change scores as the dependent variable. The variables used in the model included: Age, 
gender, BMI, living alone status, preoperative WOMAC score, ASA score, flexion ROM, 
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flexion contracture (1 and 2), varus/valgus knee deformity (1,2,3 and 4), PCL prosthesis 
design, component fixation method, postoperative complications, still would have surgery 
(still do 1 and 2), wished surgery was sooner (surgery sooner 1 and 2) and lastly the 
gender by PCL prosthesis design interaction term. Based on this model neither the PCL 
prosthesis design (P=0.263) nor gender (P=0.510) impact WOMAC change scores. In 
addition our interaction term was not significant (p=0.516) indicating that gender and 
PCL design do not interact to impact WOMAC change scores. Interestingly the following 
variables were significant for their impact on WOMAC change scores: age, BMI, 
dependency for ADL, preoperative WOMAC scores, flexion ROM, valgus deformity 
(deformity < 15°), varus deformity (deformity < 15°), postoperative complications and 
patient’s perception of surgery (still would have surgery and wished surgery was sooner).  
 
The percentage of variance explained by our model, for WOMAC change scores 
was 51.4 percent. The gender by PCL design interaction term for WOMAC change scores 
was not significant (P=0.516) as seen in figure 3.1. This figure shows the distribution of 
WOMAC change scores among patients categorized based on PCL design and gender. 
The frequency represents the number of patients that fall on a certain WOMAC change 
score. This figure demonstrates that due to the absence of an interaction, PCL retaining 
procedures and PCL sacrificing procedures provide similar WOMAC change scores 
regardless of the patient’s gender. PCL prosthesis design was also not significant (P= 
0.263) with WOMAC change score. We also found that 97.2% of our patients had 
positive WOMAC change scores (improved), while 0.5% remained neutral and 2.3% 
worsened after the surgery. 
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Figure 3.1: The effect of posterior cruciate ligament (PCL) design on WOMAC 
change scores stratified based on gender. Men and women showed similar WOMAC 
change scores (adjusted) regardless of PCL design (P=0.516). 
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To investigate whether patient satisfaction is impacted by the gender and PCL 
prosthesis design interaction, we used the same model for our multivariate analysis: age, 
gender, BMI, total preoperative WOMAC score, ASA 2 categories, dependency for ADL, 
living alone status, cemented components, varus knee deformity, valgus knee deformity, 
flexion contracture, flexion range of motion, PCL design, PCL design surgical procedure, 
still do and surgery sooner. Similar to our WOMAC change score variables we used the 
following dummy variables: flexion contracture (flexion contracture 1 and 2), varus knee 
deformity and valgus knee deformity (varus/valgus deformity 1,2,3 and 4), wished 
surgery was sooner (surgery sooner 1 and 2) and would still have surgery (still do 1 and 
2). Table 3.3 shows the result of our multivariate analysis using the variables mentioned 
above as covariates.  
 The results seen in table 3.3 are quite different than the results seen from the 
multivariate analysis for the WOMAC change scores. In contrast to the previous model 
that showed ten variables impacted WOMAC change score, there were very few variables 
that impact postoperative patient satisfaction. In particular neither the gender variable (p 
= 0.722) nor the PCL prosthesis design (p = 0.422) had a significant impact on patient 
satisfaction. Moreover, the gender-PCL prosthesis design interaction term did not have a 
significant effect on patient satisfaction. The only variables that have a significant effect 
on patient satisfaction were: age, varus deformity (deformity<15°), post-operative 
complications and the patient’s perception of the surgery (whether they would still have 
the surgery).  
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Table 3.3 - The impact of gender*PCL prosthesis design interaction on patient 
satisfaction. This table shows the multivariate analysis with patient satisfaction as the 
dependent variable. Both gender and PCL prosthesis design do not have a significant 
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impact on patient satisfaction. In addition, the interaction between the two variables does 
not have a significant (P=0.384) effect on postoperative satisfaction.  
 
 
 
The percentage of variance that is explained by our model for patient satisfaction 
was 17.2%. The previous multivariate analysis (for WOMAC change scores) showed that 
the gender by PCL design interaction term for patient satisfaction was not significant 
(P=0.384). On average, both men and women reported satisfied on the satisfaction scale, 
which indicated that there were no significant gender differences with satisfaction after 
primary unilateral TKA (P>0.05) as seen in figure 3.2. This figure shows the percentage 
of patients that fall into each satisfaction category, stratified based on gender and PCL 
design. The men and women do not differ in their post-operative satisfaction, whether the 
PCL was retained or sacrificed (P>0.05).  
However, men and women differed significantly on their response to the question 
of whether they would still have the surgery again if they could go back in time (P<0.05). 
75% of the women and 77% of men reported that they would have the surgery again if 
gone back in time (P<0.05). 70% of women reported that their expectation from the 
surgery was met as compared to 69% of men (P>0.05). 74.7% of women indicated that 
they would have had their surgery earlier, as compared to 76.7% of men (P<0.05).  
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Figure 3.2 - The effect of posterior cruciate ligament (PCL) design on patient 
satisfaction stratified based on gender. Patient satisfaction does not differ significantly 
between men and women, regardless of whether the PCL retained or sacrificed (P=0.384). 
The average response for the satisfaction questionnaire was “satisfied” for both men and 
women. For PCL retaining procedures, 29% of women reported satisfied vs. 28% of men. 
For PCL sacrificing procedures, 30% of women reported satisfied compared to 29% in 
men.   
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Chapter 4: 
Discussion 
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4.0 – Discussion overview 
The main purpose of this study was to determine whether the interaction between 
gender and PCL design, has an impact on patient-reported outcomes. For this study, 
subjective/ self-report measures were utilized to investigate the health related quality of 
life of the patient following total knee arthroplasty. This was a historical analysis of the 
prospectively collected OJRR database. A total of 1613 patients (989 females and 624 
males) were included in this study. The results of this study centered around two major 
outcomes: (a) WOMAC change scores and (b) patient satisfaction of participants after the 
knee surgery intervention. Where relevant each of these outcomes will be discussed in the 
contexts of: (1) gender, (2) PCL prosthesis design and (3) gender-PCL prosthesis design 
interaction.  
 
4.1 – Study Conclusions 
To answer the main question inquired in the introduction, this study concluded 
that the interaction between patient gender and the PCL prosthesis design does not 
significantly impact WOMAC change scores or patient satisfaction following primary 
unilateral total knee arthroplasty. With regard to our patient-reported outcomes, several 
findings warrant discussion.  
 
4.1.1 – Gender 
The gender distribution in this study (61% female, 39% male) was very similar to 
those reported in other studies 5-8. Preoperatively our female patients had higher BMI and 
lower WOMAC scores than males. Also there were more females (12%) with a 
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preoperative valgus deformity than men (5.5%). With regards to patient-reported 
outcomes, our multivariate regression analysis showed that gender does not impact either 
WOMAC change scores or patient satisfaction.  
Although our interaction term didn’t influence patient-reported outcomes, we did 
find gender differences in our covariates. Notably, men and women were significantly 
different in age, BMI, joint deformity (varus, valgus and flexion contracture), flexion 
range of motion, dependency for their activities of daily living, preoperative WOMAC 
scores and post-operative WOMAC scores. In particular, women had lower absolute 
scores in all three domains, both pre-operatively and post-operatively. Although the 
women’s absolute scores were lower, their change in WOMAC scores was larger than 
that of men (P<0.05). The postoperative score of those patients will be lower relative to 
patients who had a better preoperative score 7. We agree with other studies, that both men 
and women should not delay surgery after the decision point for surgery. To achieve the 
best outcome, it is advantageous to receive the knee replacement surgery earlier 45. We 
also recommend that the patients understand that the worse their preoperative conditions, 
the more difficult it is to achieve a desired outcome after surgery. This way, patients 
would readjust their expectations going into the surgery, knowing that delaying the 
surgery has an impact on postoperative results45. Likewise, it would be easier for the 
patient to respond to the satisfaction questionnaire in a more realistic manner.  
Although gender differences are apparent in HRQoL assessments, it is still 
controversial why these differences exist48. Some studies identified anatomic differences 
between male and female knees 38, 41. Although, there are a number of well-documented 
anatomic differences between the genders, this provides only one possible explanation 49. 
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For example, some men may have femoral anatomy more closely resembling that of a 
woman, or some women may have tibial anatomy that is similar to that of men. This 
explains why the gender specific knee implant industry has not been fully able to 
correctly restore female joint anatomy while improving clinical function 49. Although 
gender specific knee implants might be beneficial to some women or some men, there 
might still be a small percentage of patients that will not be appropriately treated with the 
gender specific implants49. We believe that the gender differences observed are 
multifactorial. Some studies have suggested that the patient height and body morphology 
(i.e. endomorph, mesomorph, ectomorph) also play a role in the observed differences in 
clinical outcomes 49. Johnson et al. 50 concluded that although there are well-established 
anatomic differences in shape of the knees of men and women, there does not seem to be 
any major benefit from gender specific TKA implants 50.  
 
4.1.2 – PCL prosthesis design 
In general, TKAs are very successful but the decision whether the PCL should be 
sacrificed or retained, remains controversial 49. The proponents of PCL retaining method 
emphasize the importance of PCL in balance, and claim that PCL acts as a biological 
stabilizer, reduces the stress at the boundary between the bone and prosthesis and absorbs 
the shearing forces 1, 51. The opponents claim that the PCL sacrificing prosthesis enables 
for better postoperative ROM and a better capability of climbing stairs 51. In addition 
some studies indicated that this prosthesis prevents posterior subluxation of the tibia. This 
is where significant gender differences are observed as more females show 
anteroposterior laxity than males 51. Even though both sides (retain vs. sacrifice) represent 
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valid arguments, most studies that compare the two procedures have concluded that the 
retention of the PCL may not be the sole determinant of good function after TKA 51. 
Similarly, our multivariate analysis showed that the PCL prosthesis design does not 
impact patient-reported outcomes. In fact the rate of PCL retaining and PCL sacrificing 
procedures were not significantly different (P>0.05) among men and women. A study by 
Ching-Jen Wang et al. 51 suggested that perhaps the success of the TKA is more 
dependent on the surgical technique and total knee designs rather than the excision of the 
PCL. In our study five total knee designs were recorded (2 PCL retaining and 3 PCL 
sacrificing). The designs that were used were: retaining medial pivot, retaining standard, 
sacrificing constrained, sacrificed deep dish and sacrificed post cam. We observed that 
there was no gender differences (p>0.05) observed between the different designs. That is 
to say, 50% of our recorded procedures were done via retaining standard and 43% of the 
procedures were done using sacrificed post cam. Although we had the total knee design 
variable, it would have been statistically incorrect to use total knee design with PCL 
prosthesis design in our multivariate analysis model because the common data between 
the two variables would compete with one another, as the Pearson correlation showed that 
these two variables are highly correlated to one another. This will generate bias in the 
results, as these two variables are competing for their impact on WOMAC change score 
and patient satisfaction. Perhaps future studies can look at an interaction between the 
gender and the total knee design.  
 
4.1.3 – Gender-PCL prosthesis design interaction  
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The decision to retain or sacrifice the PCL has been largely dependent on the 
favor and experience of the orthopedic surgeon 47. The clinical implication of this study 
was to investigate whether knee surgeons should compromise their surgical preference, 
based on the gender of their patient. The analysis of our patient-reported outcomes 
indicated that the interaction between patient gender and PCL design did not have a 
significant impact on WOMAC change scores and post operative patient satisfaction. In 
other words, both men and women had similar WOMAC change scores and showed 
similar levels of postoperative satisfaction (satisfied), regardless of whether they received 
a PCL sacrificed prosthesis or PCL retaining prosthesis. This leads us to believe gender 
should not be a consideration in the decision to retain or sacrifice the posterior cruciate 
ligament during TKA.  
 Although there are well-documented gender differences in TKA outcomes and 
prosthesis design no one has looked at the interaction between gender and PCL prosthesis 
design. This makes it is impossible/very difficult to compare our results to that of other 
studies. Regardless, our study determined that this interaction does not have a significant 
effect on patient-reported outcomes.  
Although both WOMAC change scores and satisfaction scores are valid, they are 
still subjective measurements. We suggest that, in order to fully investigate this gender 
interaction, objective measurements (i.e. performance-based measurements) should be 
included in gender-related health research.    
 
4.2 – Contribution to current state of Knowledge 
	  	  
92	  
Many studies have looked into gender differences involved with covariates that 
influence HRQoL, but to our knowledge there has been no large-scale study that has 
verified the existence of a PCL design-gender interaction when WOMAC change scores 
and patient satisfaction are the outcomes of interest. In the literature, there are some 
indications that suggest the interaction of gender and PCL design should be present 18, 23, 52, 
54. For example, McKean et al., 55 showed that there are gender interactions in gait 
parameters. Osteoarthritic women that are at earlier stages of the disease exhibit 
biomechanics that are more consistent with OA gait than the male counterparts. These 
and other established biomechanical differences between genders should suggest that men 
and women interact differently with the PCL design prosthesis. Although controversial, 
part of the reason behind the gender specific implant industry is due to the potential 
existence of gender-implant design interaction influencing patient-reported outcomes 55, 56. 
In our study, however, we did not find a significant interaction between gender and PCL 
prosthesis design and functional outcome or patient satisfaction. Perhaps the observed 
gender differences in WOMAC change scores could be a result of gender differences in 
disability and not a result of physiological/anatomical differences 55. It is well established 
that men and women deal with degenerative osteoarthritis and the treatments differently64. 
That is, in our study, WOMAC change scores and patient satisfaction did not change 
significantly with PCL sacrificing and retaining procedures.  
Although our interaction term (gender-PCL prosthesis design) did not influence 
patient-reported outcomes, we did find gender differences in our covariates. One of our 
findings was that men achieved higher function, had less pain and less stiffness after their 
surgery. Although the average postoperative scores for women in all the three WOMAC 
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domains was lower than men, women experienced higher improvement (WOMAC 
change score) in function, more reduction in pain and stiffness than men. Some studies 
suggest that having lower baseline WOMAC scores provides a higher potential for 
improvement. To be exact, the postoperative score of those patients will be lower relative 
to patients who had a better preoperative score 7, 20, 56. Taenzer et al., 48 suggested that this 
observation is made possible because the female candidates wait longer to have their 
surgeries. Hawker et al., 18 also reported similar results indicating that regardless of the 
joint affected, women had a higher prevalence of arthritis, worse symptoms and greater 
disability before the surgery. Lower pre-operative scores provide a potential for more 
improvement after the surgery, relative to their baseline conditions. We found similar 
results as our female patients had lower pre-operative scores but higher WOMAC change 
scores than men. Karlson et al., 57 qualitavely noted that women were more cautious and 
were willing to accept a higher decline in function, more pain and stiffness before 
accepting surgery. It is possible that the difference between men and women observed in 
WOMAC change scores may not be due to physiological gender differences but rather the 
preoperative state of the patient 54. Our findings support this notion as we found that pre-
operative function is correlated and predictive of WOMAC change score (P<0.05). We 
agree with Karlson et al., 57, that both men and women should not delay surgery after the 
decision point. To achieve the best outcome, it is advantageous to receive the knee 
replacement surgery earlier. We also recommend that the patient understands that the 
worse the preoperative conditions, the more difficult it is to achieve a desired outcome 
after the surgery. This way, patients would readjust their expectations going into the 
surgery, knowing that delaying the surgery has an impact on postoperative results 27. 
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Likewise, it would be easier for the patient to respond to the satisfaction questionnaire in 
a more precise manner.  
Furthermore, Bourne et al. 6 determined that contemporary TKA implants, as used 
in this study, do not improve patient satisfaction levels. This may explain why we were 
not able to detect gender-PCL design interaction with patient satisfaction. Bourne et al 
also found that patient expectation is the more important predictor of patient satisfaction. 
Similarly, Mahomed et al. 25, 45 suggested that patient expectations should be discussed 
with the surgeon, to be realistic. Since the majority of our female patients had lower pre-
operative WOMAC scores and this is predictive of lower post-operative total WOMAC 
scores, we recommend that referring physicians talk about the risks of surgery delay and 
the risks of worsening preoperative function with the female patients.   
 
4.3 – Study Strengths 
There are a number of notable strengths to this study. To our knowledge this is the 
first study that looked at the impact of gender-PCL prosthesis design interaction on 
patient-reported outcomes. In addition this study had a large cohort of 1613 patients. This 
study suggests that the interaction between gender and PCL prosthesis design is not 
significant enough to impact WOMAC change scores. To patients and doctors this is an 
important finding. For patients it means that their gender does not have an impact on their 
capability to improve their WOMAC scores, regardless of whether the surgeon chooses to 
retain or sacrifice the PCL. This is specifically important for patients with a knee 
deformity such as valgus or varus, where the surgeon is more likely to use a PCL 
sacrificing prosthesis for better ligament balance 51. Furthermore, for surgeons this means 
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that they don’t have to alter their preference to retain or sacrifice the PCL, based on the 
gender of their patient.  
The second main strength of this study is that we used WOMAC change scores for 
our HRQoL outcome instead of using absolute post WOMAC scores. Historically many 
studies have used preoperative and postoperative scores but it is the change score that 
truly represents the effect on an intervention on surgical outcomes. This is primarily 
because absolute preoperative and postoperative scores are usually affected by many 
factors such as comorbidities and the disease state. But by taking the difference between 
the postoperative scores and preoperative scores, we eliminate the secondary effect of 
existing conditions on absolute scores. For example, in our study men showed higher 
postoperative scores on all the three domains of WOMAC but when WOMAC scores 
were calculated, women on average had higher WOMAC change scores than men.  
MacDonald et al., 58 suggested that without the consideration of the WOMAC change 
scores, conclusions that are drawn are more likely to present the bias in the test itself 
rather than the true effect of the knee arthroplasty.  
Third, along with WOMAC change scores, we used postoperative patient 
satisfaction, which is not commonly used in TKA studies. Generally, the outcomes of 
TKAs have been assessed by surgeons using unvalidated scoring systems where the 
patient is asked about their level of pain and their ability to return to specific activities 9. 
The surgeon then measures range of motion and joint stability 9. A number of studies that 
have assessed quality of life after TKAs have found that although the surgeon may find 
that the patient has improved, the patient may not agree that their quality of life has 
improved after the surgery 59. This emphasizes the need to incorporate a more patient 
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oriented assessment of quality of life such as patient satisfaction questionnaire. Our study 
was one of the few studies that used patient satisfaction along with the WOMAC 
questionnaire to assess the quality of life of the patient following the therapeutic/surgical 
intervention. In particular we showed that men and women show similar satisfaction 
regardless of whether the surgeon chooses to retain or sacrifice the PCL.  In our study, on 
average, both men and women were satisfied in both the PCL retaining group and the 
PCL sacrificing group.  
Another study strength is that we used the OJRR for the database. This registry 
was collected primarily from southwestern Ontario, which includes roughly two million 
Canadians and one of the most ethnically diverse sample populations 6. In particular, this 
patient sample is well representative of Canada’s ethically diverse population 6. Therefore 
this database had a high external validity. The data for the OJRR study was collected 
prospectively for this observation cohort study, so the internal validity is less than that of 
a clinical trial but still higher than other retrospective studies. The OJRR database was 
used in many publications 6-9, 13, 27. Conclusions drawn from the analyses of the OJRR can 
be used as general information to inform clinical and treatment plans and decisions 
affecting specific patients. 
 One final strength for this study is that we were able to control for many variables 
that could have affected our dependent variables of interest. There were a few studies that 
have controlled for some important covariates, but they have left out other important 
variables that have been established to be associated with patient-reported outcomes as 
reviewed in section 1.8 above. Our extensive literature review allowed us to choose the 
appropriate covariates for WOMAC change scores and patient-reported outcomes.    
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4.4 – Study limitations 
This study was a historical analysis of a prospectively collected database. Thus 
there are some study limitations that were not in our control. One of our study limitations 
was the scoring system for patient satisfaction. Our scoring system was out of a five-point 
scale. Studies looking at self-reported questionnaires, such as that done by Jamieson et al. 
60 suggested that in patient self-reports, the response categories have a rank order but the 
interval between the values can’t be presumed equal. Secondly, there is a high tendency 
for the human mind to choose the middle point 61. This was evident as both men (28.8%) 
and women (29.6%) on average chose 3 (satisfied), on the 5-point scale (0-4), for their 
patient satisfaction. A study by Guyatt et al. 61, also suggested that a 7-point likert scale is 
more appropriate for patient self reported questionnaires.  
Another study limitation is the capturing time points of the pre-operative 
WOMAC questionnaire for the OJRR. The preoperative WOMAC was collected at the 
decision time for surgery. Since the WOMAC was only measured twice, at decision time 
and at the one-year follow-up, the reliability of the pre-operative WOMAC scores may be 
reduced, as WOMAC scores can worsen depending on the waiting time6. The waiting 
times can range from 3 months to 2 years 6. This poses a problem as the patient may have 
a much lower WOMAC going into the surgery as compared to when it was measured at 
decision time for surgery17. Since it is well known that lower pre-operative WOMAC 
scores are associated with lower post-operative WOMAC scores, this becomes a big 
problem for women that choose to delay their surgery after the decision point. Once they 
agree to go through the surgery, it is likely that their WOMAC scores will be lower than 
what was recorded on the decision point. At the actual time of surgery they can have a 
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much lower WOMAC score7, 45. For future studies we would recommend to have 3 
measurements of WOMAC. Ideally, we would like to see captured time points at decision 
time for surgery, followed by one immediately (within a week) before the surgery and a 
post-operative measurement at the one-year follow-up.  
One further limitation is that we did not evaluate the effect of having the patella 
resurfaced or non-resurfaced, as residual patellar pain may have influenced the functional 
outcome or patient satisfaction. However, the vast majority of patients in this study had 
all three components cemented, suggesting the patella had been resurfaced in the majority 
of patients.  
Although many studies use self-reported measures, there is still a controversy 
regarding the validity of the use of self-reported functional status measures as opposed to 
the observed physical performance measures24. In our database the preoperative 
quadriceps strength was not measured. It has been validated by multiple studies that pre-
operative quadriceps is a strong predictor of post-operative functional recovery 62. 
Patients with degenerative osteoarthritis experience joint pain and worsening function, 
which reduces their capability of being active 62. This becomes more exaggerated in later 
stages, when the patient becomes inactive for a long period of time. Long periods of 
inactivity leads to muscle atrophy and decrease in muscle strength 62. Some studies 
suggest that muscle atrophy and decrease in strength, can be detrimental to the 
postoperative recovery 62. Given the variance in wait times in our study, some patients 
may remain inactive for as long as one year. Therefore to completely capture the pre and 
post-operative state of the patient, we believe that it is necessary to include a validated 
physical assessment 62.  
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Most large-scale studies, such as ours, use the self-report measures, as they are 
inexpensive, easily administered, and are able to evaluate multiple aspects of function in a 
single test. Unfortunately since most of our patients are elderly, possible errors in 
memory or judgment, and an inability to answer accurately may affect our self-reported 
WOMAC questionnaires.  
 
4.5 – Future Studies 
One important factor that has been underestimated in many studies is the presence 
of an interaction between gender and knee deformity. Perhaps for future studies we can 
look at two new interaction terms. One interaction of interest is between the varus knee 
deformity and gender. In this study we demonstrated that there are significant gender 
differences involved with knee deformity (both valgus and varus). This suggests that 
there is a possibility that the interaction between knee deformity and gender might impact 
patient-reported outcomes. Similarly we can also look at the interaction between gender 
and valgus knee deformity and its impact on patient-reported outcomes. Although both of 
these interaction terms are classified as knee deformity they are mutually exclusive, as 
one with a varus deformity cannot also have a valgus deformity. Studying these 
interactions is important on two levels. First, 84% of our patients had some kind of knee 
deformity (varus or valgus). Therefore, studying this group of patients will provide a new 
insight as to why we can’t achieve better patient-reported outcomes, even with such great 
improvements in technology and prosthetic designs. Second, if the gender-deformity 
interaction impacts patient-reported outcomes, this would indicate that the gender and 
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knee alignment of the patient should be considered in the decision making of knee 
surgeons.  
4.6 – Summary 
Our gender-PCL prosthesis design interaction variable did not impact our patient-reported 
outcomes. Our linear regression analysis findings show that PCL design does not affect 
WOMAC change scores and post-operative patient satisfaction. Gender of the patient 
does not affect either of the patient-reported outcomes. We accept the alternate hypothesis 
that WOMAC change scores and patient satisfaction are not influenced by the interaction 
between gender and PCL design. Surgeons need not make decisions about PCL design 
based on the gender of the patient. 
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and Knee Replacement Surgery 
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DATE OF REVIEW BY CRIC: February 29, 2012 
Health Sciences REB#: 18682E 
 
Please be advised that the above project was reviewed by the Clinical Research 
Impact Committee and the project: 
 Was Approved 
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LABORATORIES, ETC. BEFORE STARTING THIS PROTOCOL.  
THE RESEARCH OFFICE NUMBER MUST BE USED WHEN 
COMMUNICATING WITH THESE AREAS. 
Dr. David Hill 
V.P. Research 
Lawson Health Research Institute 
 
All future correspondence concerning this study should include the Research Office 
Review Number and should be directed to Sherry Paiva, CRIC Liaison, LHSC, Rm. C210, 
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Appendix B – OJRR knee questionnaire 
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Appendix C – WOMAC and patient satisfaction questionnaire 
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Appendix D – Data dictionary 
Table Name Field Name Field Text 
Field 
Value 
Join
t 
Dev
ice 
rwDemograph
ics address text 0 
eith
er all 
rwDemograph
ics admission Date text 0 
eith
er all 
rwDemograph
ics alternate Contact Yes 1 
eith
er all 
rwDemograph
ics alternate Contact No 0 
eith
er all 
rwDemograph
ics alternate Name text 0 
eith
er all 
rwDemograph
ics 
alternate 
Telephone text 0 
eith
er all 
rwDemograph
ics apartment text 0 
eith
er all 
rwDemograph
ics chart no text 0 
eith
er all 
rwDemograph
ics city text 0 
eith
er all 
rwDemograph
ics consent Yes 1 
eith
er all 
rwDemograph
ics consent No 0 
eith
er all 
rwDemograph
ics consultation Date text 0 
eith
er all 
rwDemograph
ics consult Delayed Yes 1 
eith
er all 
rwDemograph
ics consult Delayed No 0 
eith
er all 
rwDemograph
ics date Of Birth text 0 
eith
er all 
rwDemograph
ics decision Date text 0 
eith
er all 
rwDemograph
ics first name text 0 
eith
er all 
rwDemograph
ics gender Male 2 
eith
er all 
rwDemograph
ics gender Female 1 
eith
er all 
rwDemograph healthCardnumber text 0 eith all 
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ics er 
rwDemograph
ics hipleft Yes 1 
eith
er all 
rwDemograph
ics hipleft No 0 
eith
er all 
rwDemograph
ics hip right No 0 
eith
er all 
rwDemograph
ics hip right Yes 1 
eith
er all 
rwDemograph
ics hospital Number text 0 
eith
er all 
rwDemograph
ics initial text 0 
eith
er all 
rwDemograph
ics knee left Yes 1 
eith
er all 
rwDemograph
ics knee left No 0 
eith
er all 
rwDemograph
ics knee right No 0 
eith
er all 
rwDemograph
ics knee right Yes 1 
eith
er all 
rwDemograph
ics lastImplantdate text 0 
eith
er all 
rwDemograph
ics language     
eith
er all 
rwDemograph
ics language English 
Englis
h 
eith
er all 
rwDemograph
ics language French French 
eith
er all 
rwDemograph
ics last name text 0 
eith
er all 
rwDemograph
ics physician ID text 0 
eith
er all 
rwDemograph
ics postal code text 0 
eith
er all 
rwDemograph
ics procedure Primary 1 
eith
er all 
rwDemograph
ics procedure Revision 2 
eith
er all 
rwDemograph
ics province Quebec 2 
eith
er all 
rwDemograph province Alberta 4 eith all 
	  	  
127	  
ics er 
rwDemograph
ics province Saskatchewan 10 
eith
er all 
rwDemograph
ics province Yukon 13 
eith
er all 
rwDemograph
ics province 
Prince Edward 
Island 9 
eith
er all 
rwDemograph
ics province British Columbia 5 
eith
er all 
rwDemograph
ics province Ontario 1 
eith
er all 
rwDemograph
ics province 
North West 
Terrories 11 
eith
er all 
rwDemograph
ics province Newfoundland 6 
eith
er all 
rwDemograph
ics province New Brunswick 7 
eith
er all 
rwDemograph
ics province Manitoba 3 
eith
er all 
rwDemograph
ics province Nunavit 12 
eith
er all 
rwDemograph
ics province Out of Country 14 
eith
er all 
rwDemograph
ics province Nova Scotia 8 
eith
er all 
rwDemograph
ics referral Date text 0 
eith
er all 
rwDemograph
ics referral Source 
General 
Practitioner 3 
eith
er all 
rwDemograph
ics referral Source Specialist - Ortho 1 
eith
er all 
rwDemograph
ics referral Source Specialist - Other 2 
eith
er all 
rwDemograph
ics referral Status No 0 
eith
er all 
rwDemograph
ics referral Status Yes 1 
eith
er all 
rwDemograph
ics removal Date text 0 
eith
er all 
rwDemograph
ics surgery Canceled Patient Diseased 3 
eith
er all 
rwDemograph surgery Canceled Cancelled By 1 eith all 
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ics Patient er 
rwDemograph
ics surgery Canceled 
Cancelled By 
Surgeon 2 
eith
er all 
rwDemograph
ics surgery Canceled Not Collected 5 
eith
er all 
rwDemograph
ics surgery Canceled Referred On 4 
eith
er all 
rwDemograph
ics surgery Date text 0 
eith
er all 
rwDemograph
ics 
surgeryDelayedHo
spital Yes 1 
eith
er all 
rwDemograph
ics 
surgeryDelayedHo
spital No 0 
eith
er all 
rwDemograph
ics 
surgeryDelayedMe
dical Yes 1 
eith
er all 
rwDemograph
ics 
surgeryDelayedMe
dical No 0 
eith
er all 
rwDemograph
ics surgeryDelayedNo Yes 1 
eith
er all 
rwDemograph
ics surgeryDelayedNo No 0 
eith
er all 
rwDemograph
ics 
surgeryDelayedPat
ient Yes 1 
eith
er all 
rwDemograph
ics 
surgeryDelayedPat
ient No 0 
eith
er all 
rwDemograph
ics telephone text 0 
eith
er all 
rwDevices antiProtrusioRing No 0 
eith
er all 
rwDevices antiProtrusioRing Yes 1 
eith
er all 
rwDevices bipolor Yes 1 
eith
er all 
rwDevices bipolor No 0 
eith
er all 
rwDevices calcarReplacement No 0 
eith
er all 
rwDevices calcarReplacement Yes 1 
eith
er all 
rwDevices captureCup Yes 1 
eith
er all 
rwDevices captureCup No 0 eith all 
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er 
rwDevices catelogueNumber text 0 
eith
er all 
rwDevices deviceSize 26mm 2 
eith
er all 
rwDevices deviceSize 32mm 4 
eith
er all 
rwDevices deviceSize other 6 
eith
er all 
rwDevices deviceSize 22mm 1 
eith
er all 
rwDevices deviceSize > 32mm 5 
eith
er all 
rwDevices deviceSize 28mm 3 
eith
er all 
rwDevices deviceType One Piece 2 hip 
acet
abul
arco
mpo
nent 
rwDevices deviceType All Poly 1 hip 
acet
abul
arco
mpo
nent 
rwDevices deviceType Metal Backed 0 
kne
e 
tibia
lbas
epla
te 
rwDevices deviceType All Poly Insert 1 
kne
e 
tibia
lbas
epla
te 
rwDevices deviceType 
Surface Not 
Replaced 0 hip 
fem
oral 
hea
d 
rwDevices deviceType Surface Replaced 1 hip 
fem
oral 
hea
d 
rwDevices fixation Not Cemented 1 eith all 
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er 
rwDevices fixation Cemented 2 
eith
er all 
rwDevices fixation Cemented Yes 1 
eith
er all 
rwDevices fixation Cemented No 0 
eith
er all 
rwDevices fixationGritBlasted No 0 
eith
er all 
rwDevices fixationGritBlasted Yes 1 
eith
er all 
rwDevices fixationHACoated No 0 
eith
er all 
rwDevices fixationHACoated Yes 1 
eith
er all 
rwDevices fixation Other Yes 1 
eith
er all 
rwDevices fixation Other No 0 
eith
er all 
rwDevices 
fixationPorousInGr
owth Yes 1 
eith
er all 
rwDevices 
fixationPorousInGr
owth No 0 
eith
er all 
rwDevices fixationPressFit No 0 
eith
er all 
rwDevices fixationPressFit Yes 1 
eith
er all 
rwDevices increased Offset No 0 
eith
er all 
rwDevices increased Offset Yes 1 
eith
er all 
rwDevices lateral Yes 1 
eith
er all 
rwDevices lateral No 0 
eith
er all 
rwDevices lateralized No 0 
eith
er all 
rwDevices lateralized Yes 1 
eith
er all 
rwDevices lot Number text 0 
eith
er all 
rwDevices manufacturer J&J/DePuy 3 eith all 
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er 
rwDevices manufacturer Other 9 
eith
er all 
rwDevices manufacturer Zimmer 8 
eith
er all 
rwDevices manufacturer Wright Medical 7 
eith
er all 
rwDevices manufacturer 
Sulzer/Centerpuls
e 6 
eith
er all 
rwDevices manufacturer 
Stryker/Osteonics/
Howmedica 5 
eith
er all 
rwDevices manufacturer Ceraver 2 
eith
er all 
rwDevices manufacturer Biomet 1 
eith
er all 
rwDevices manufacturer 
Smith & Nephew 
Richards 4 
eith
er all 
rwDevices material 
Polyethyl 
Standard 1 
eith
er 
acet
abul
arin
sertl
iner 
rwDevices material Metal 5 
eith
er 
acet
abul
arin
sertl
iner 
rwDevices material Ceramic Zirconia 4 
eith
er 
acet
abul
arin
sertl
iner 
rwDevices material Ceramic Alumina 3 
eith
er 
acet
abul
arin
sertl
iner 
rwDevices material 
Polyethyl Cross-
linked 2 
eith
er 
acet
abul
arin
sertl
iner 
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rwDevices material Other 6 
eith
er 
acet
abul
arin
sertl
iner 
rwDevices material Cobalt Chrome 1 
eith
er 
fem
oral 
hea
d 
rwDevices material Ceramic Zirconia 2 
eith
er 
fem
oral 
hea
d 
rwDevices material Ceramic Alumina 3 
eith
er 
fem
oral 
hea
d 
rwDevices material Other 5 
eith
er 
fem
oral 
hea
d 
rwDevices material Oxinium 4 
eith
er 
fem
oral 
hea
d 
rwDevices method MethodTwo 2 
eith
er all 
rwDevices method Onlay 2 
kne
e 
pate
llar 
rwDevices method Inset 1 
kne
e 
pate
llar 
rwDevices method Method One 1 
eith
er all 
rwDevices mobile Bearing Yes 1 
eith
er all 
rwDevices mobile Bearing No 0 
eith
er all 
rwDevices modular No 0 
eith
er all 
rwDevices modular Yes 1 
eith
er all 
rwDevices pcl Sacrifice 2 eith all 
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er 
rwDevices pcl Retaining 1 
eith
er all 
rwDevices replaced No 1 
eith
er all 
rwDevices replaced Yes 2 
eith
er all 
rwDevices retaining Standard 1 
eith
er all 
rwDevices retaining Medial Pivot 2 
eith
er all 
rwDevices sacrifice Medial Pivot 4 
eith
er all 
rwDevices sacrifice Post & Cam 1 
eith
er all 
rwDevices sacrifice Constrained 3 
eith
er all 
rwDevices sacrifice Hinged 5 
eith
er all 
rwDevices sacrifice Deep-dished 2 
eith
er all 
rwDevices screws No 0 
eith
er all 
rwDevices screws Yes 1 
eith
er all 
rwDevices stem Type Standard Modular 2 
eith
er all 
rwDevices stem Type Fixed 1 
eith
er all 
rwDevices stem Type Offset Modular 3 
eith
er all 
rwDevices wiremesh No 0 
eith
er all 
rwDevices wiremesh Yes 1 
eith
er all 
rwOperativeJo
int approach Direct Lateral 3 hip all 
rwOperativeJo
int approach Intravastus 3 
kne
e all 
rwOperativeJo
int approach 
Lateral - 
Minimally 
Invasive 6 
kne
e all 
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rwOperativeJo
int approach 
Medial - 
Minimally 
Invasive 5 
kne
e all 
rwOperativeJo
int approach MIS - 2 Incision 7 hip all 
rwOperativeJo
int approach Medial - Standard 1 
kne
e all 
rwOperativeJo
int approach Anterolateral 2 hip all 
rwOperativeJo
int approach MIS - Posterior 6 hip all 
rwOperativeJo
int approach Other 7 
kne
e all 
rwOperativeJo
int approach Posterolateral 4 hip all 
rwOperativeJo
int approach Smith/Peterson 1 hip all 
rwOperativeJo
int approach Subvastus 4 
kne
e all 
rwOperativeJo
int approach MIS - Anterior 5 hip all 
rwOperativeJo
int approach Lateral - Standard 2 
kne
e all 
rwOperativeJo
int arthroFibrosis No 0 
eith
er all 
rwOperativeJo
int arthroFibrosis Yes 1 
eith
er all 
rwOperativeJo
int asepticLoosening No 0 
eith
er all 
rwOperativeJo
int asepticLoosening Yes 1 
eith
er all 
rwOperativeJo
int bonefracture Yes 1 
eith
er all 
rwOperativeJo
int bonefracture No 0 
eith
er all 
rwOperativeJo
int compartment Patellofemoral 3 
eith
er all 
rwOperativeJo
int compartment Medial 1 
eith
er all 
rwOperativeJo
int compartment Lateral 2 
eith
er all 
rwOperativeJo computerAssisted Yes 1 eith all 
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int er 
rwOperativeJo
int computerAssisted No 0 
eith
er all 
rwOperativeJo
int 
failedPatellarComp
onent Yes 1 
eith
er all 
rwOperativeJo
int 
failedPatellarComp
onent No 0 
eith
er all 
rwOperativeJo
int implantFracture Yes 1 
eith
er all 
rwOperativeJo
int implantFracture No 0 
eith
er all 
rwOperativeJo
int infection No 0 
eith
er all 
rwOperativeJo
int infection Yes 1 
eith
er all 
rwOperativeJo
int instability No 0 
eith
er all 
rwOperativeJo
int instability Yes 1 
eith
er all 
rwOperativeJo
int 
lateralReleaseValg
usKnee No 0 
eith
er all 
rwOperativeJo
int 
lateralReleaseValg
usKnee Yes 1 
eith
er all 
rwOperativeJo
int 
lateralRetinacularR
elease No 0 
eith
er all 
rwOperativeJo
int 
lateralRetinacularR
elease Yes 1 
eith
er all 
rwOperativeJo
int malposition Yes 1 
eith
er all 
rwOperativeJo
int malposition No 0 
eith
er all 
rwOperativeJo
int 
medialEpicondyle
Osteotomy No 0 
eith
er all 
rwOperativeJo
int 
medialEpicondyle
Osteotomy Yes 1 
eith
er all 
rwOperativeJo
int 
medialReleaseVaru
sKnee Yes 1 
eith
er all 
rwOperativeJo
int 
medialReleaseVaru
sKnee No 0 
eith
er all 
rwOperativeJo
int osteolysis Yes 1 
eith
er all 
rwOperativeJo osteolysis No 0 eith all 
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int er 
rwOperativeJo
int patellaMaltracking No 0 
eith
er all 
rwOperativeJo
int patellaMaltracking Yes 1 
eith
er all 
rwOperativeJo
int performedRemoval Yes 1 
eith
er all 
rwOperativeJo
int performedRemoval No 0 
eith
er all 
rwOperativeJo
int polyWear No 0 
eith
er all 
rwOperativeJo
int polyWear Yes 1 
eith
er all 
rwOperativeJo
int procedure 
R2 (Second 
Revision) 3 
eith
er all 
rwOperativeJo
int procedure 
R1 (First 
Revision) 2 
eith
er all 
rwOperativeJo
int procedure Primary 1 
eith
er all 
rwOperativeJo
int procedure 
>R3 (More Than 
Third Revision) 5 
eith
er all 
rwOperativeJo
int procedure 
R3 (Third 
Revision) 4 
eith
er all 
rwOperativeJo
int 
quadricepsTurnDo
wn Yes 1 
eith
er all 
rwOperativeJo
int 
quadricepsTurnDo
wn No 0 
eith
er all 
rwOperativeJo
int reasonOther No 0 
eith
er all 
rwOperativeJo
int reasonOther Yes 1 
eith
er all 
rwOperativeJo
int reattachtrochanter No 0 
eith
er all 
rwOperativeJo
int reattachtrochanter Yes 1 
eith
er all 
rwOperativeJo
int rectusSnip No 0 
eith
er all 
rwOperativeJo
int rectusSnip Yes 1 
eith
er all 
rwOperativeJo
int 
replaceTibialPolyli
ner Yes 1 
eith
er all 
rwOperativeJo replaceTibialPolyli No 0 eith all 
	  	  
137	  
int ner er 
rwOperativeJo
int specialStepsNone Yes 1 
eith
er all 
rwOperativeJo
int specialStepsNone No 0 
eith
er all 
rwOperativeJo
int specialTechnique 
Extended 
Trochanteric 2 
eith
er all 
rwOperativeJo
int specialTechnique None 1 
eith
er all 
rwOperativeJo
int specialTechnique Slide-Trochanteric 3 
eith
er all 
rwOperativeJo
int specialTechnique 
Trans-
Trochanteric 4 
eith
er all 
rwOperativeJo
int stagedProcedure 
Two Stage 
Reimplantation 2 
eith
er all 
rwOperativeJo
int stagedProcedure 
One Stage 
Reimplantation 1 
eith
er all 
rwOperativeJo
int temporaryImplant 
Antibiotic 
(temporary) 
arthroplasty 
inserted 4 
eith
er all 
rwOperativeJo
int temporaryImplant 
Antibiotic spacer 
inserted 3 
eith
er all 
rwOperativeJo
int temporaryImplant 
None (No Spacer 
Inserted) 1 
eith
er all 
rwOperativeJo
int temporaryImplant 
Spacer (non 
Antibiotic) 
inserted 2 
eith
er all 
rwOperativeJo
int 
tibialTubercleOste
otomy No 0 
eith
er all 
rwOperativeJo
int 
tibialTubercleOste
otomy Yes 1 
eith
er all 
rwOperativeJo
int unicompartmental No 0 
eith
er all 
rwOperativeJo
int unicompartmental Yes 1 
eith
er all 
rwOperativeJo
int 
unresurfacedPatell
a Yes 1 
eith
er all 
rwOperativeJo
int 
unresurfacedPatell
a No 0 
eith
er all 
rwOperativeP
atient 
anaestheticCombin
ation Yes 1 
eith
er all 
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rwOperativeP
atient 
anaestheticCombin
ation No 0 
eith
er all 
rwOperativeP
atient 
anaestheticEpidura
l No 0 
eith
er all 
rwOperativeP
atient 
anaestheticEpidura
l Yes 1 
eith
er all 
rwOperativeP
atient anaestheticGeneral No 0 
eith
er all 
rwOperativeP
atient anaestheticGeneral Yes 1 
eith
er all 
rwOperativeP
atient 
anaestheticLocalIn
filtration No 0 
eith
er all 
rwOperativeP
atient 
anaestheticLocalIn
filtration Yes 1 
eith
er all 
rwOperativeP
atient 
anaestheticNerveBl
ock No 0 
eith
er all 
rwOperativeP
atient 
anaestheticNerveBl
ock Yes 1 
eith
er all 
rwOperativeP
atient anaestheticSpinal No 0 
eith
er all 
rwOperativeP
atient anaestheticSpinal Yes 1 
eith
er all 
rwOperativeP
atient environment Laminar Air Flow 2 
eith
er all 
rwOperativeP
atient environment Body Exhaust 3 
eith
er all 
rwOperativeP
atient environment 
Laminar Air 
FLow & Body 
Exhaust 4 
eith
er all 
rwOperativeP
atient environment Standard 1 
eith
er all 
rwOperativeP
atient environment Ultraviolet 5 
eith
er all 
rwOperativeP
atient 
surgeryDelayedHo
spital Yes 1 
eith
er all 
rwOperativeP
atient 
surgeryDelayedHo
spital No 0 
eith
er all 
rwOperativeP
atient 
surgeryDelayedMe
dical Yes 1 
eith
er all 
rwOperativeP
atient 
surgeryDelayedMe
dical No 0 
eith
er all 
rwOperativeP surgeryDelayedNo Yes 1 eith all 
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atient er 
rwOperativeP
atient surgeryDelayedNo No 0 
eith
er all 
rwOperativeP
atient 
surgeryDelayedPat
ient Yes 1 
eith
er all 
rwOperativeP
atient 
surgeryDelayedPat
ient No 0 
eith
er all 
rwPostopPatie
nt antibiotics No 0 
eith
er all 
rwPostopPatie
nt antibiotics Yes 1 
eith
er all 
rwPostopPatie
nt asa No 0 
eith
er all 
rwPostopPatie
nt asa Yes 1 
eith
er all 
rwPostopPatie
nt 
blindedClinicalTria
l No 0 
eith
er all 
rwPostopPatie
nt 
blindedClinicalTria
l Yes 1 
eith
er all 
rwPostopPatie
nt duration More24 2 
eith
er all 
rwPostopPatie
nt duration Less24 1 
eith
er all 
rwPostopPatie
nt footpump Yes 1 
eith
er all 
rwPostopPatie
nt footpump No 0 
eith
er all 
rwPostopPatie
nt lmwHeparin No 0 
eith
er all 
rwPostopPatie
nt lmwHeparin Yes 1 
eith
er all 
rwPostopPatie
nt other Yes 1 
eith
er all 
rwPostopPatie
nt other No 0 
eith
er all 
rwPostopPatie
nt 
pneumaticStocking
s No 0 
eith
er all 
rwPostopPatie
nt 
pneumaticStocking
s Yes 1 
eith
er all 
rwPostopPatie
nt 
prophylaxisInHosp
ital No 0 
eith
er all 
rwPostopPatie prophylaxisInHosp Yes 1 eith all 
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nt ital er 
rwPostopPatie
nt SCHeparin No 0 
eith
er all 
rwPostopPatie
nt SCHeparin Yes 1 
eith
er all 
rwPostopPatie
nt warfarin No 0 
eith
er all 
rwPostopPatie
nt warfarin Yes 1 
eith
er all 
rwPreopJoint arthodesis No 0 
eith
er all 
rwPreopJoint arthodesis Yes 1 
eith
er all 
rwPreopJoint 
arthoscopicDebride
ment Yes 1 
eith
er all 
rwPreopJoint 
arthoscopicDebride
ment No 0 
eith
er all 
rwPreopJoint 
arthroscopicMenis
ectomy Yes 1 
eith
er all 
rwPreopJoint 
arthroscopicMenis
ectomy No 0 
eith
er all 
rwPreopJoint femoralOsteotomy No 0 
eith
er all 
rwPreopJoint femoralOsteotomy Yes 1 
eith
er all 
rwPreopJoint flexContracture None 1 
eith
er all 
rwPreopJoint flexContracture => 15 3 
eith
er all 
rwPreopJoint flexContracture < 15 2 
eith
er all 
rwPreopJoint flexion Yes 2 
eith
er all 
rwPreopJoint flexion No 1 
eith
er all 
rwPreopJoint fractureFixation Yes 1 
eith
er all 
rwPreopJoint fractureFixation No 0 
eith
er all 
rwPreopJoint Hemiarthroplasy No 0 
eith
er all 
rwPreopJoint Hemiarthroplasy Yes 1 eith all 
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er 
rwPreopJoint kneeDeformity Varus 3 
eith
er all 
rwPreopJoint kneeDeformity Valgus 2 
eith
er all 
rwPreopJoint kneeDeformity None 1 
eith
er all 
rwPreopJoint 
kneeDeformitySev
erity => 15 2 
eith
er all 
rwPreopJoint 
kneeDeformitySev
erity < 15 1 
eith
er all 
rwPreopJoint ligamentRepair No 0 
eith
er all 
rwPreopJoint ligamentRepair Yes 1 
eith
er all 
rwPreopJoint openMenisectomy Yes 1 
eith
er all 
rwPreopJoint openMenisectomy No 0 
eith
er all 
rwPreopJoint patellectomy No 0 
eith
er all 
rwPreopJoint patellectomy Yes 1 
eith
er all 
rwPreopJoint pelvicOsteotomy Yes 1 
eith
er all 
rwPreopJoint pelvicOsteotomy No 0 
eith
er all 
rwPreopJoint previousNone Yes 1 
eith
er all 
rwPreopJoint previousNone No 0 
eith
er all 
rwPreopJoint previousOther Yes 1 
eith
er all 
rwPreopJoint previousOther No 0 
eith
er all 
rwPreopJoint 
primaryJointDiagn
osis Other 10 hip all 
rwPreopJoint 
primaryJointDiagn
osis 
Degenerative 
Osteoarthritis 1 hip all 
rwPreopJoint 
primaryJointDiagn
osis 
Inflammatory 
Arthritis 2 hip all 
rwPreopJoint primaryJointDiagn Post Traumatic 5 hip all 
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osis Osteoarthritis 
rwPreopJoint 
primaryJointDiagn
osis Tumour 8 hip all 
rwPreopJoint 
primaryJointDiagn
osis Infection 9 hip all 
rwPreopJoint 
primaryJointDiagn
osis Tumour 7 
kne
e all 
rwPreopJoint 
primaryJointDiagn
osis Osteonecrosis 4 hip all 
rwPreopJoint 
primaryJointDiagn
osis 
Post Traumatic 
Osteoarthritis 3 
kne
e all 
rwPreopJoint 
primaryJointDiagn
osis Other 8 
kne
e all 
rwPreopJoint 
primaryJointDiagn
osis 
Acute Hip 
Fracture 7 hip all 
rwPreopJoint 
primaryJointDiagn
osis 
Degenerative 
Osteoarthritis 1 
kne
e all 
rwPreopJoint 
primaryJointDiagn
osis Osteonecrosis 4 
kne
e all 
rwPreopJoint 
primaryJointDiagn
osis 
Childhood Hip 
Problem 3 hip all 
rwPreopJoint 
primaryJointDiagn
osis Acute Fracture 5 
kne
e all 
rwPreopJoint 
primaryJointDiagn
osis 
Inflammatory 
Arthritis 2 
kne
e all 
rwPreopJoint 
primaryJointDiagn
osis Old Hip Fracture 6 hip all 
rwPreopJoint 
primaryJointDiagn
osis Infection 6 
kne
e all 
rwPreopJoint 
PrimaryTotalHipA
rthroplasty No 0 
eith
er all 
rwPreopJoint 
PrimaryTotalHipA
rthroplasty Yes 1 
eith
er all 
rwPreopJoint 
primaryTotalKnee
Arthroplasty No 0 
eith
er all 
rwPreopJoint 
primaryTotalKnee
Arthroplasty Yes 1 
eith
er all 
rwPreopJoint revision No 0 
eith
er all 
rwPreopJoint revision Yes 1 
eith
er all 
rwPreopJoint secondaryAcuteFra No 0 eith all 
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cture er 
rwPreopJoint 
secondaryAcuteFra
cture Yes 1 
eith
er all 
rwPreopJoint 
secondaryAcuteHi
pFracture No 0 
eith
er all 
rwPreopJoint 
secondaryAcuteHi
pFracture Yes 1 
eith
er all 
rwPreopJoint 
secondarychildhoo
dHipProblem No 0 
eith
er all 
rwPreopJoint 
secondarychildhoo
dHipProblem Yes 1 
eith
er all 
rwPreopJoint 
secondaryDegener
ativeOA Yes 1 
eith
er all 
rwPreopJoint 
secondaryDegener
ativeOA No 0 
eith
er all 
rwPreopJoint secondaryInfection Yes 1 
eith
er all 
rwPreopJoint secondaryInfection No 0 
eith
er all 
rwPreopJoint 
secondaryInflamm
atoryArthritis No 0 
eith
er all 
rwPreopJoint 
secondaryInflamm
atoryArthritis Yes 1 
eith
er all 
rwPreopJoint secondaryNone Yes 1 
eith
er all 
rwPreopJoint secondaryNone No 0 
eith
er all 
rwPreopJoint 
SecondaryOldHipF
racture No 0 
eith
er all 
rwPreopJoint 
SecondaryOldHipF
racture Yes 1 
eith
er all 
rwPreopJoint 
secondaryOsteonec
rosis Yes 1 
eith
er all 
rwPreopJoint 
secondaryOsteonec
rosis No 0 
eith
er all 
rwPreopJoint secondaryOther Yes 1 
eith
er all 
rwPreopJoint secondaryOther No 0 
eith
er all 
rwPreopJoint 
secondaryPostTrau
maticOA Yes 1 
eith
er all 
rwPreopJoint secondaryPostTrau No 0 eith all 
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maticOA er 
rwPreopJoint secondaryTumour Yes 1 
eith
er all 
rwPreopJoint secondaryTumour No 0 
eith
er all 
rwPreopJoint 
stageResectionArth
roplasy No 0 
eith
er all 
rwPreopJoint 
stageResectionArth
roplasy Yes 1 
eith
er all 
rwPreopJoint surfaceReplaced Yes 1 
eith
er all 
rwPreopJoint surfaceReplaced No 0 
eith
er all 
rwPreopJoint tibialOsteotomy No 0 
eith
er all 
rwPreopJoint tibialOsteotomy Yes 1 
eith
er all 
rwPreopJoint 
unicondylarArthro
plasty Yes 1 
eith
er all 
rwPreopJoint 
unicondylarArthro
plasty No 0 
eith
er all 
rwPreopJoint unispacer Yes 1 
eith
er all 
rwPreopJoint unispacer No 0 
eith
er all 
rwPreopPatien
t ASA 
P2 (Mild Systemic 
Disease) 2 
eith
er all 
rwPreopPatien
t ASA 
P1 (Normal 
Healthy) 1 
eith
er all 
rwPreopPatien
t ASA 
P4 (Life 
Threatening) 4 
eith
er all 
rwPreopPatien
t ASA 
P3 (Severe 
Systemic Disease) 3 
eith
er all 
rwPreopPatien
t height text 0 
eith
er all 
rwPreopPatien
t 
leftHipComorbidit
y 
No Joint 
Complaints 4 
eith
er all 
rwPreopPatien
t 
leftHipComorbidit
y Not Yet Assessed 5 
eith
er all 
rwPreopPatien
t 
leftHipComorbidit
y Replaced 2 
eith
er all 
rwPreopPatien leftHipComorbidit Replaced & 3 eith all 
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t y Symptomatic er 
rwPreopPatien
t 
leftHipComorbidit
y Symptomatic 1 
eith
er all 
rwPreopPatien
t 
leftKneeComorbidi
ty Replaced 2 
eith
er all 
rwPreopPatien
t 
leftKneeComorbidi
ty Not Yet Assessed 5 
eith
er all 
rwPreopPatien
t 
leftKneeComorbidi
ty Symptomatic 1 
eith
er all 
rwPreopPatien
t 
leftKneeComorbidi
ty 
Replaced & 
Symptomatic 3 
eith
er all 
rwPreopPatien
t 
leftKneeComorbidi
ty 
No Joint 
Complaints 4 
eith
er all 
rwPreopPatien
t OtherDisease No 0 
eith
er all 
rwPreopPatien
t OtherDisease Yes 1 
eith
er all 
rwPreopPatien
t 
rightHipComorbidi
ty Symptomatic 1 
eith
er all 
rwPreopPatien
t 
rightHipComorbidi
ty 
Replaced & 
Symptomatic 3 
eith
er all 
rwPreopPatien
t 
rightHipComorbidi
ty Replaced 2 
eith
er all 
rwPreopPatien
t 
rightHipComorbidi
ty 
No Joint 
Complaints 4 
eith
er all 
rwPreopPatien
t 
rightHipComorbidi
ty Not Yet Assessed 5 
eith
er all 
rwPreopPatien
t 
rightKneeComorbi
dity 
No Joint 
Complaints 4 
eith
er all 
rwPreopPatien
t 
rightKneeComorbi
dity 
Replaced & 
Symptomatic 3 
eith
er all 
rwPreopPatien
t 
rightKneeComorbi
dity Symptomatic 1 
eith
er all 
rwPreopPatien
t 
rightKneeComorbi
dity Not Yet Assessed 5 
eith
er all 
rwPreopPatien
t 
rightKneeComorbi
dity Replaced 2 
eith
er all 
rwPreopPatien
t weight text 0 
eith
er all 
rwSurgery ABGraftNone Yes 1 
eith
er all 
rwSurgery ABGraftNone No 0 eith all 
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er 
rwSurgery anterior No 0 
eith
er all 
rwSurgery anterior Yes 1 
eith
er all 
rwSurgery antibioticCement Vancomycin 4 
eith
er all 
rwSurgery antibioticCement Erythromycin 2 
eith
er all 
rwSurgery antibioticCement Gentamycin 5 
eith
er all 
rwSurgery antibioticCement None 1 
eith
er all 
rwSurgery antibioticCement Other 6 
eith
er all 
rwSurgery antibioticCement Tobramycin 3 
eith
er all 
rwSurgery 
antibioticMixingm
ethod Vacuum-mixed 1 
eith
er all 
rwSurgery 
antibioticMixingm
ethod Centrifuge 2 
eith
er all 
rwSurgery 
antibioticMixingm
ethod Manually Mixed 3 
eith
er all 
rwSurgery antibioticsAdded No 0 
eith
er all 
rwSurgery antibioticsAdded Yes 1 
eith
er all 
rwSurgery antibioticType Gentamycin 4 
eith
er all 
rwSurgery antibioticType Vancomycin 3 
eith
er all 
rwSurgery antibioticType Tobramycin 2 
eith
er all 
rwSurgery antibioticType Erythromycin 1 
eith
er all 
rwSurgery antibioticType Other 5 
eith
er all 
rwSurgery cementName Zimmer 6 
eith
er all 
rwSurgery cementName CMW 2 
eith
er all 
rwSurgery cementName Other 7 eith all 
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er 
rwSurgery cementName Palacos 5 
eith
er all 
rwSurgery cementName Simplex 1 
eith
er all 
rwSurgery cementName Osteobond 4 
eith
er all 
rwSurgery cementName VersaBond 3 
eith
er all 
rwSurgery cementNone No 0 
eith
er all 
rwSurgery cementNone Yes 1 
eith
er all 
rwSurgery dAllograft No 0 
eith
er all 
rwSurgery dAllograft Yes 1 
eith
er all 
rwSurgery dAutograft Yes 1 
eith
er all 
rwSurgery dAutograft No 0 
eith
er all 
rwSurgery deviceType TypeOne 0 
eith
er all 
rwSurgery deviceType TypeThree 2 
eith
er all 
rwSurgery deviceType TypeTwo 1 
eith
er all 
rwSurgery 
dImpactmorsellize
d Yes 1 
eith
er all 
rwSurgery 
dImpactmorsellize
d No 0 
eith
er all 
rwSurgery distal No 0 
eith
er all 
rwSurgery distal Yes 1 
eith
er all 
rwSurgery dMorsellized Yes 1 
eith
er all 
rwSurgery dMorsellized No 0 
eith
er all 
rwSurgery dOnlay Yes 1 
eith
er all 
rwSurgery dOnlay No 0 eith all 
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er 
rwSurgery dStructural Yes 1 
eith
er all 
rwSurgery dStructural No 0 
eith
er all 
rwSurgery dSubstitute No 0 
eith
er all 
rwSurgery dSubstitute Yes 1 
eith
er all 
rwSurgery FBGraftNone Yes 1 
eith
er all 
rwSurgery FBGraftNone No 0 
eith
er all 
rwSurgery FMANone Yes 1 
eith
er all 
rwSurgery FMANone No 0 
eith
er all 
rwSurgery Full No 0 
eith
er all 
rwSurgery Full Yes 1 
eith
er all 
rwSurgery Lateral Yes 1 
eith
er all 
rwSurgery Lateral No 0 
eith
er all 
rwSurgery Medial No 0 
eith
er all 
rwSurgery Medial Yes 1 
eith
er all 
rwSurgery mixingMethod Centrifuge 2 
eith
er all 
rwSurgery mixingMethod Manually Mixed 3 
eith
er all 
rwSurgery mixingMethod Vacuum-mixed 1 
eith
er all 
rwSurgery pAllograft No 0 
eith
er all 
rwSurgery pAllograft Yes 1 
eith
er all 
rwSurgery pAutograft Yes 1 
eith
er all 
rwSurgery pAutograft No 0 eith all 
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er 
rwSurgery pMorsellized No 0 
eith
er all 
rwSurgery pMorsellized Yes 1 
eith
er all 
rwSurgery pOnlay Yes 1 
eith
er all 
rwSurgery pOnlay No 0 
eith
er all 
rwSurgery posterior Yes 1 
eith
er all 
rwSurgery posterior No 0 
eith
er all 
rwSurgery pStructural No 0 
eith
er all 
rwSurgery pStructural Yes 1 
eith
er all 
rwSurgery pSubstitute Yes 1 
eith
er all 
rwSurgery pSubstitute No 0 
eith
er all 
rwSurgery retaining Medial Pivot 2 
eith
er all 
rwSurgery retaining Standard 1 
eith
er all 
rwSurgery TBGraftNone Yes 1 
eith
er all 
rwSurgery TBGraftNone No 0 
eith
er all 
rwSurgery TMANone No 0 
eith
er all 
rwSurgery TMANone Yes 1 
eith
er all 
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Appendix E – Value assignment to variables 
Devices 
 
/* Manufacturer variables *; 
Manu_femoralcomponent     
Manu_femoralstem 
Manu_patellar                       
Manu_tibialbaseplate                
Manu_tibialpolyinsert               
Manu_tibialstem                     
 
/* Manufacturer names *; 
Biomet 1 
Ceraver 2 
J&J/DePuy 3 
Smith & Nephew Richards 4 
Stryker/Osteonics/Howmedica 5 
Sulzer/CenterPulse 6 
Wright Medical 7 
Zimmer 8 
Other 9 
*/ 
 
HA_Coated_femoralcomponent          
PorousIngrowth_femoralcomponent     
PressFit_femoralcomponent           
 
HA_Coated_tibialbaseplate           
PorousIngrowth_tibialbaseplate      
 
THICKNESS_tibialpolyinsert          
 
PorousIngrowth_patellar             
 
MOBILEBEARING_tibialbaseplate       
 
PCLRetaining_tibialbaseplate        
PCLSacrificing_tibialbaseplate      
 
STEMTYPE_femoralstem                
STEMTYPE_tibialstem                 
 
cemented_femoralcomponent           
cemented_patellar                   
cemented_tibialbaseplate            
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/* Device catalogue Numbers */ 
femoralcomponent                    
femoralstem                         
patellar 
tibialbaseplate                     
tibialpolyinsert                    
tibialstem                          
                            
/* unique record identifier */ 
patientid                           
 
replaced_femoralcomponent           
replaced_femoralstem                
replaced_patellar                   
replaced_tibialbaseplate            
replaced_tibialpolyinsert           
replaced_tibialstem                 
screws_tibialbaseplate              
 
sxjt  = K  
 
zero = no augment and 1 equals yes augment used 
 
** femoral metal augments **; 
Kfma=0; 
if FMANONE=0 then Kfma=1; 
KdisFMA=DISTAL; 
KposFMA=POSTERIOR; 
KantFMA=ANTERIOR;  
** tibial metal augments **; 
Ktma=0; 
if TMANONE=0 then Ktma=1; 
KmedTMA=MEDIAL;  
KlatTMA=LATERAL;  
KfulTMA=FULL; 
** femoral bone grafts **; 
Kfbg=0; 
if FBGRAFTNONE=0 then Kfbg=1; 
KalloFBG=PALLOGRAFT; 
KautoFBG=PAUTOGRAFT;     
KbsubFBG=PSUBSTITUTE;      
KmorseFBG=PMORSELLIZED;  
KonlayFBG=PONLAY;   
KstrucFBG=PSTRUCTURAL;  
** tibial bone grafts **; 
Ktbg=0; 
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if TBGRAFTNONE=0 then Ktbg=1; 
KalloTBG=DALLOGRAFT; 
KautoTBG=DAUTOGRAFT;     
KbsubTBG=DSUBSTITUTE;      
KmorseTBG=DMORSELLIZED;  
KonlayTBG=DONLAY;   
KstrucTBG=DSTRUCTURAL;  
 
Kcementused=0; 
if CEMENTNONE=0 then Kcementused=1; 
 
                   
 
/* APPROACH */ 
/* hip  
1= Smith/Peterson  
2= Anterolateral  
3= Direct Lateral  
4= Posterolateral   
5= MIS - Anterior   
6= MIS - Posterior  
7= MIS - 2 Incision */ 
/* knee 
1= Medial - Standard  
2= Lateral - Standard  
3= Intravastus        
4= Subvastus          
5= Medial - Minimally Invasive  
6= Lateral - Minimally Invasive  
7= Other */ 
 
/* special steps - knee */ 
LATERALRETINACULARRELEASE 
MEDIALRELEASEVARUSKNEE  
LATERALRELEASEVALGUSKNEE 
RECTUSSNIP 
QUADRICEPSTURNDOWN 
TIBIALTUBERCLEOSTEOTOMY 
MEDIALEPICONDYLEOSTEOTOMY 
COMPUTERASSISTED 
/* special steps - knee */ 
SPECIALTECHNIQUE; 
/* 
specialTechnique: None = 1 
specialTechnique: Extended Trochanteric = 2 
specialTechnique: Slide-Trochanteric = 3 
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specialTechnique: Trans-Trochanteric = 4 
 
 
ANYSPECIALSTEPSDONE=0 (no) 
ANYSPECIALSTEPSDONE=1 (yes) 
 
ANTIBIOTICS 0=no; 1=yes; DURATION (of antibiotics): LE 24 hrs=1; GT 24 hrs=2 
 
DVTPROPHYL_ASA                 = ASA; 
DVTPROPHYL_BLINDEDCLINICALTRIAL = BLINDEDCLINICALTRIAL; 
DVTPROPHYL_FOOTPUMP             = FOOTPUMP; 
DVTPROPHYL_LMWHEPARIN         = LMWHEPARIN; 
DVTPROPHYL_PNEUMATICSTOCKINGS = PNEUMATICSTOCKINGS; 
DVTPROPHYL_SCHEPARIN         = SCHEPARIN; 
DVTPROPHYL_WARFARIN             = WARFARIN; 
 
PROPHYLAXISINHOSPITAL 0=no, 1=yes *; 
 
PCLRetaining_tibialbaseplate 
retaining Standard 1 
retaining Medial Pivot 2 
 
 
  PCLSacrificing_tibialbaseplate 
sacrifice Medial Pivot 4 
sacrifice Post & Cam 1 
sacrifice Constrained 3 
sacrifice Hinged 5 
sacrifice Deep-dished 2 
 
 
 
 
 
Stemtype 
 
stemType 
Standard 
Modular 2 
stemType Fixed 1 
stemType 
Offset 
Modular 3 
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age        /* age on surgery date in years */ 
genderNUM  /* GenderNUM:[0=female; 1=male] */ 
bmi        /* body mass index in kg per meter squared */ 
 
/* American Society of Anesthesiologists Physical Status (ASA-PS) score: assigned by 
Anesthesiologist at time of surgery  */ 
asaNUM 
/* ASA scoring: healthy (1); mild disease (2); severe disease (3); incapacitating disease 
(4) */ 
 
charncat   /* Charnely category: AB vs C: C=walking would be limited if hips and knees 
were normal; A/B=any other combination of prior TJRs AND C does not apply */ 
 
employ     /* [NOTWRKUNEMPL= Not working or unemployed; RETIRED(self-
explanatory); WORKFTORPT=working full or part-time] */                    
 
MedsInflamm /* do you take meds for inflammation? Y/N; n/a = question was not 
available to patients-instituted in ojrr much later */ 
MedsPain    /* do you take meds for pain? Y/N; n/a = question was not available to 
patients-instituted in ojrr much later */ 
      
livealoneNUM  /* Do you live alone? [0=no; 1=yes] */                    
dependelseNUM /* Do you depend on anyone else for help with ADL? [0=no; 1=yes] */                
dependyouNUM  /* Does anyone depend on you for help with ADL? [0=no; 1=yes] */                
 
REFERRALSTATUS /* Referral status at consult time is [0=re-assessment (patient seen 
by surgeon before); 1=new referral] */                       
primdx         /* Primary joint diagnosis is: 
                    ChildHipPr = Childhood Hip problem 
                    DegOA      = Degenarative Osteoarthritis 
                    Infection  = Joint Infection 
                         InflArth   = Inflammatory Arthritis 
                    OsteoNecr  = Osteonecrosis 
                         OtherDx    = Diagnosis is Other than those listed on             
                                      data collection forms 
                        PstTraumOA = Post Traumatic Osteoarthrtis */ 
                         
jointcount     /* TJR surgery is [1=unilateral; 2=bilateral] */ 
 
sxjt           /* Surgical Joint is [H=hip; K=knee] */ 
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/* Wait times */ 
refSx          /* [time in days between referral to an orthopaedic surgeon  and TJR surgery ] 
there are many missing values*/ 
decSx          /* [time in days between decision to proceed with surgery [by both surgeon 
and patient] and TJR surgery ] there are no missing values */ 
 
/* Baseline WOMAC scores captured at decision for surgery: scale is 0-100 (worst to best 
state) there are no missing values */ 
b_funcRV100    /* function domain  */ 
b_painRV100    /* pain domain      */ 
b_stiffRV100   /* stiffness domain */ 
b_totalRV100   /* total score (all 3 domains) */ 
 
/* 1yr post-op WOMAC scores captured 1yr after surgery: scale is 0-100 (worst to best 
state) there are no missing values */ 
s_funcRV100    /* function domain  */ 
s_painRV100    /* pain domain      */ 
s_stiffRV100   /* stiffness domain */ 
s_totalRV100   /* total score (all 3 domains) */ 
 
complNUM       /* Post-op complication: Between discharge and 1yr followup, did you 
have a post-op complication requiring hospital admission? [0=no; 1=yes] – captured in 1-
yr post-op follow-up survey */     
      
Satisfaction   /* Overall satisfaction rating: 4='Very Satisfied'; 3='Satisfied'; 2='Neutral'; 
1='Dissatisfied'; 0='Very Disatisfied'] – captured in 1-yr post-op follow-up survey */                  
expectMet2     /* Were your expectations for surgery met? Yes, No or I had no 
expectations – captured in 1-yr post-op follow-up survey */                
expectLevel    /* If not, were they too high, just right or too low? – captured in 1-yr post-
op follow-up survey */ 
stilldoNUM     /* If you could do it all over again would you? [1='Yes'; 0='Uncertain'; -
1='No'] – captured in 1-yr post-op follow-up survey */                     
sxSoonerNUM;   /* Do you wish you had your TJR surgery sooner? [1='Yes'; 
0='Uncertain'; -1='No'] – captured in 1-yr post-op follow-up survey */ 
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Appendix F- Permissions 
Figure 1.1 - permission 
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Figure 1.3 - permission 
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Figure 1.4 - permission 
Dear Ryan Milan 
We hereby grant you permission to reproduce the material detailed below at no charge in 
your thesis, in print and on the Western University web site subject to the following 
conditions: 
  
1.         If any part of the material to be used (for example, figures) has appeared in our 
publication with credit or acknowledgement to another source, permission must 
also be sought from that source.  If such permission is not obtained then that 
material may not be included in your publication/copies. 
  
2.         Suitable acknowledgment to the source must be made, either as a footnote or in a 
reference list at the end of your publication, as follows: 
  
“This article was published in Publication title, Vol number, Author(s), Title of 
article, Page Nos, Copyright Elsevier (or appropriate Society name) (Year).” 
  
3.         Your thesis may be submitted to your institution in either print or electronic form. 
  
4.         Reproduction of this material is confined to the purpose for which permission is 
hereby given. 
  
5.         This permission is granted for non-exclusive world English rights only.  For other 
languages please reapply separately for each one required.  Permission excludes 
use in an electronic form other than as specified above.  Should you have a 
specific electronic project in mind please reapply for permission. 
  
6.         This includes permission for the Library and Archives of Canada to supply single 
copies, on demand, of the complete thesis.  Should your thesis be published 
commercially, please reapply for permission. 
  
Yours sincerely 
 Jennifer Jones  Rights Associate 
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Figure 1.5 – permission  
 
NATURE PUBLISHING GROUP LICENSE TERMS AND CONDITIONS 
Nov 16, 2012 
This is a License Agreement between Ryan Milan ("You") and Nature Publishing Group 
("Nature Publishing Group") provided by Copyright Clearance Center ("CCC"). The 
license consists of your order details, the terms and conditions provided by Nature 
Publishing Group, and the payment terms and conditions. 
 
All payments must be made in full to CCC. For payment instructions, please see 
information listed at the bottom of this form. 
License Number 3030930703605 
License date Nov 16, 2012 
Licensed content publisher Nature Publishing Group 
Licensed content publication Nature Reviews Molecular Cell Biology 
Licensed content title Matrix metalloproteinases and the regulation of tissue remodelling 
Licensed content author Andrea Page-McCaw, Andrew J. Ewald, Zena Werb 
Licensed content date Mar 1, 2007 
Volume number 8 
Issue number 3 
Type of Use reuse in a thesis/dissertation 
Requestor type non-commercial (non-profit) 
Format electronic 
Portion figures/tables/illustrations 
Number of 
figures/tables/illustrations 
1 
High-res required n/a 
Figures FIGURE 3 | Skeletal phenotypes of MMP mutants. 
Author of this NPG article no 
Your reference number 
Title of your thesis / 
dissertation 
IMPACT OF GENDER AND CRUCIATE DESIGN INTERACTION ON 
KNEE REPLACEMENT 
Expected completion date Nov 2012 
Estimated size (number of 
pages) 
150 
Total 0.00 USD 
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Figure 1.6, 1.8, 1.11 – Permission 
11/20/2012 
 
Dear Ryan Milan, 
 
Nucleus Medical Media grants you permission to use the illustrations provided at no 
charge, in his PhD thesis for use at Western University. Attribution for use of the 
illustrations should be noted as " Medical Illustration Copyright © 2012. Nucleus Medical 
Media, www.nucleusinc.com." 
 
This permission is granted for non-exclusive world English rights only.  For other 
languages please reapply separately for each one required.  Permission excludes use in an 
electronic form other than as specified above.  Should you have a specific electronic 
project in mind please reapply for permission. 
  
This includes permission for the Library and Archives of Canada to supply single copies, 
on demand, of the complete thesis.   
 
Should the thesis be published commercially, the illustrations must be licensed for further 
publication. 
 
Kind regards, 
 
Niky Jones 
Content Licensing Coordinator 
Nucleus Medical Media, Inc. 
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Figure 1.7 – permission  
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Figure 1.9, 1.10 – permission 
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Figure 1.12, 1.13 – permission 
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Figure 1.14 – permission 
 
Material Authorization Form / Agreement 
Non-Branded Images (for non-HCP) 
 
 
October 19, 2012 
Via Email 
 
 
Dear Ryan Milan: 
 
This letter will confirm the terms and conditions upon which Zimmer, Inc. (“Zimmer”) will permit you to 
use Zimmer’s digital assets as more fully identified below (“Material”).  All Material is and at all times 
shall remain the sole and exclusive property of Zimmer.   
 
The specific Material covered by this letter agreement is attached as Attachment A. The Material may be 
used solely for the Intended Use identified below.  By executing this letter, you agree to not use the 
Material for any purpose other than the Intended Use set forth below.   
• Intended Use:   The Material shall be used to demonstrate the different angles of knee 
flexion range of motion in your thesis report introduction, with the source referenced in 
the figure legend and in the bibliography. 
• Additional Requirements:  You agree that you will not use the Zimmer name or the 
name of a specific Zimmer product in connection with or in relation to the Material.  
Further, you will not use the name of any Zimmer competitor or any product of a Zimmer 
competitor in connection with or in relation to your use of the Material.   
 
Except as expressly authorized in this letter agreement, you are not authorized to copy, reproduce, 
republish, modify, upload, post, transmit, create derivative works or distribute all or any part of the Material 
in any way.  You are further not permitted to archive the Material.  Modification of the Materials or use of 
the Materials for any other purpose other than the Intended Use is strictly prohibited and is a violation of 
Zimmer’s copyright, proprietary and other legal rights.  You will incorporate into your Intended Use of the 
Material an acknowledgement that the image was provided by Zimmer.  
 
We reserve, and you acknowledge, our right to withdraw this authorization at any time, with or without 
cause. In the event of such a withdrawal, you agree to immediately cease the use of the Material. All rights 
at law and equity are reserved in the event of unauthorized use, reproduction or distribution of any Material. 
 
THE MATERIAL IS PROVIDED ON AN “AS IS, WHERE IS” BASIS WITHOUT WARRANTIES OF 
ANY KIND EITHER EXPRESSED OR IMPLIED. ALL OTHER WARRANTIES, EXPRESSED OR 
IMPLIED, INCLUDING, BUT NOT LIMITED TO, IMPLIED WARRANTIES OF 
MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND NON-INFRINGEMENT ARE 
HEREBY EXPRESSLY DISCLAIMED. Under no circumstances shall Zimmer be liable for any direct, 
indirect, special or consequential damage arising out of or related to the use of, or the inability to use, the 
Material. 
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Figure 1.6 B – Permission 
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